[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f4Mr94lRV7apfC095RNDIF4rtbM2-ilNo3Db_Sso3Vk0":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":36,"phaseBuckets":86,"rows":93},"McMaster University",[4],712,false,123,59,2107629,45,563,[14,17,20,22,25,28,31,34],{"name":15,"count":16},"Aging",16,{"name":18,"count":19},"Obesity",15,{"name":21,"count":19},"Asthma",{"name":23,"count":24},"Postpartum Depression",14,{"name":26,"count":27},"Stroke",13,{"name":29,"count":30},"Venous Thromboembolism",11,{"name":32,"count":33},"Cardiovascular Diseases",9,{"name":35,"count":33},"Knee Osteoarthritis",[37,42,47,52,57,62,67,72,76,81],{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT04925973","Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management","2023-12","Tofacitinib 10 MG [Xeljanz]",{"nctId":43,"briefTitle":44,"date":45,"intervention":46},"NCT05742724","The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol","2024-02-16","Tetrahydrocannabinol-Cannabidiol Combination",{"nctId":48,"briefTitle":49,"date":50,"intervention":51},"NCT04202835","ATG Plus PTCy vs ATG for CGVHD Prophylaxis","2024-05-18","Cyclophosphamide",{"nctId":53,"briefTitle":54,"date":55,"intervention":56},"NCT06270147","Timing of TAP Blocks in Bariatric Surgery","2025-01-31","Bupivacaine-epinephrine",{"nctId":58,"briefTitle":59,"date":60,"intervention":61},"NCT04890938","Sputum-guided Treatment With Comprehensive Care Management in COPD - A Randomized-controlled Trial","2025-03","Sputum-guided management and comprehensive care management",{"nctId":63,"briefTitle":64,"date":65,"intervention":66},"NCT05576038","Tryptophan for Impaired AhR Signaling in Celiac Disease","2025-04-01","L-Tryptophan",{"nctId":68,"briefTitle":69,"date":70,"intervention":71},"NCT05979909","Intravesical Mitomycin C After Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma","2025-09","Mitomycin C",{"nctId":73,"briefTitle":74,"date":70,"intervention":75},"NCT02645266","Mean Visual Acuity Changes Following Five Injections of Aflibercept","Aflibercept Injection [Eylea]",{"nctId":77,"briefTitle":78,"date":79,"intervention":80},"NCT07173361","Progesterone and Muscle Protein Synthesis in Premenopausal Women (MP4-MPS)","2025-12-15","Micronized progesterone",{"nctId":82,"briefTitle":83,"date":84,"intervention":85},"NCT03824106","Frailty Rehabilitation","2025-12-31","Nutrition and Medication review",[87,88,89,90,91,92],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[94,159,185,212,230,256,281,299,331,349,367,398,416,456,497,524,550,581,599,617,635,673,709,746,764,786,811,832,854,880,906,929,953,977,995,1021,1039,1068,1086,1104,1122,1146,1164,1185,1207,1228,1259,1294,1331,1365,1407,1453,1487,1521,1545,1563,1592,1617,1635,1661,1684,1702,1726,1744,1768,1793,1811,1836,1862,1880,1906,1924,1942,1960,1985,2012,2035,2059,2077,2103,2121,2167,2200,2243,2278,2311,2346,2372,2390,2417,2435,2453,2471,2497,2515,2539,2563,2588,2612,2636,2654,2679,2697,2720,2745,2773,2800,2818,2841,2870,2888,2914,2932,2958,2984,3002,3026,3044,3069,3087,3110,3134,3152,3178,3203,3229,3253,3277,3301,3327,3345,3371,3395,3419,3451,3469,3495,3513,3531,3555,3579,3604,3630,3648,3674,3699,3717,3750,3781,3807,3842,3868,3892,3910,3933,3955,3979,4002,4025,4049,4075,4102,4120,4154,4172,4190,4208,4226,4249,4273,4291,4312,4334,4357,4379,4405,4429,4453,4471],{"intervention":95,"totalTrials":96,"cells":97},"Normal Saline",4,{"EARLY_PHASE1":98,"PHASE1":101,"PHASE2":103,"PHASE3":105,"PHASE4":127,"NA":157},{"trials":99,"activeCount":100},[],0,{"trials":102,"activeCount":100},[],{"trials":104,"activeCount":100},[],{"trials":106,"activeCount":100},[107,120],{"nctId":108,"briefTitle":109,"status":110,"phases":111,"primaryCompletion":112,"completion":112,"start":113,"enrollment":114,"conditions":115,"interventions":118},"NCT04918576","Topical Tranexamic Acid for Bilateral Breast Reduction Surgery","UNKNOWN",[90],"2024-08","2022-08",106,[116,117],"Hematoma Postoperative","Tranexamic Acid",[119,95],"Tranexamic acid",{"nctId":121,"briefTitle":122,"status":110,"phases":123,"primaryCompletion":112,"completion":112,"start":113,"enrollment":114,"conditions":124,"interventions":126},"NCT04918589","Tranexamic Acid for Alloplastic Breast Reconstruction",[90],[116,125,117],"Breast Cancer",[119,95],{"trials":128,"activeCount":156,"soonestReadout":134},[129,143],{"nctId":130,"briefTitle":131,"status":132,"phases":133,"primaryCompletion":134,"completion":135,"start":136,"enrollment":137,"conditions":138,"interventions":140},"NCT06054750","Testing Regional anesthesia Techniques For Up And Early Discharge Following Knee arthroplasty - a Feasibility Study","NOT_YET_RECRUITING",[91],"2027-03-31","2027-06-30","2025-01-01",226,[139],"Arthroplasty, Replacement, Knee",[141,142],"Ropivacaine","Normal saline",{"nctId":144,"briefTitle":145,"status":146,"phases":147,"primaryCompletion":148,"completion":148,"start":149,"enrollment":150,"conditions":151,"interventions":154},"NCT04765722","Mepolizumab for the Treatment of Chronic Cough With Eosinophilic Airways Diseases","COMPLETED",[91],"2024-11-12","2021-12-14",46,[152,153,21],"Chronic Cough","Eosinophilic Bronchitis",[155,95],"Mepolizumab",1,{"trials":158,"activeCount":100},[],{"intervention":160,"totalTrials":156,"cells":161},"Semaglutide Pen Injector",{"EARLY_PHASE1":162,"PHASE1":164,"PHASE2":166,"PHASE3":168,"PHASE4":170,"NA":183},{"trials":163,"activeCount":100},[],{"trials":165,"activeCount":100},[],{"trials":167,"activeCount":100},[],{"trials":169,"activeCount":100},[],{"trials":171,"activeCount":156,"soonestReadout":177},[172],{"nctId":173,"briefTitle":174,"status":175,"phases":176,"primaryCompletion":177,"completion":177,"start":178,"enrollment":179,"conditions":180,"interventions":182},"NCT06852391","JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity","RECRUITING",[91],"2027-12-31","2025-06-18",74,[181],"Obesity (Disorder)",[160],{"trials":184,"activeCount":100},[],{"intervention":186,"totalTrials":156,"cells":187},"Bavarian Nordic smallpox vaccine",{"EARLY_PHASE1":188,"PHASE1":190,"PHASE2":192,"PHASE3":194,"PHASE4":196,"NA":210},{"trials":189,"activeCount":100},[],{"trials":191,"activeCount":100},[],{"trials":193,"activeCount":100},[],{"trials":195,"activeCount":100},[],{"trials":197,"activeCount":156,"soonestReadout":202},[198],{"nctId":199,"briefTitle":200,"status":175,"phases":201,"primaryCompletion":202,"completion":203,"start":204,"enrollment":205,"conditions":206,"interventions":208},"NCT05745987","Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT",[91],"2026-06-01","2026-12-01","2024-09-17",3000,[207],"Monkeypox",[186,209],"Typhoid VI Polysaccharide Vaccine Injectable Solution",{"trials":211,"activeCount":100},[],{"intervention":209,"totalTrials":156,"cells":213},{"EARLY_PHASE1":214,"PHASE1":216,"PHASE2":218,"PHASE3":220,"PHASE4":222,"NA":228},{"trials":215,"activeCount":100},[],{"trials":217,"activeCount":100},[],{"trials":219,"activeCount":100},[],{"trials":221,"activeCount":100},[],{"trials":223,"activeCount":156,"soonestReadout":202},[224],{"nctId":199,"briefTitle":200,"status":175,"phases":225,"primaryCompletion":202,"completion":203,"start":204,"enrollment":205,"conditions":226,"interventions":227},[91],[207],[186,209],{"trials":229,"activeCount":100},[],{"intervention":231,"totalTrials":156,"cells":232},"Faricimab",{"EARLY_PHASE1":233,"PHASE1":235,"PHASE2":237,"PHASE3":239,"PHASE4":241,"NA":254},{"trials":234,"activeCount":100},[],{"trials":236,"activeCount":100},[],{"trials":238,"activeCount":100},[],{"trials":240,"activeCount":100},[],{"trials":242,"activeCount":156,"soonestReadout":248},[243],{"nctId":244,"briefTitle":245,"status":246,"phases":247,"primaryCompletion":248,"completion":248,"start":249,"enrollment":250,"conditions":251,"interventions":253},"NCT05610319","Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial","ACTIVE_NOT_RECRUITING",[91],"2026-12","2023-05-01",446,[252],"Diabetic Macular Edema",[231],{"trials":255,"activeCount":100},[],{"intervention":257,"totalTrials":156,"cells":258},"Inhaled corticosteroid",{"EARLY_PHASE1":259,"PHASE1":261,"PHASE2":263,"PHASE3":265,"PHASE4":267,"NA":279},{"trials":260,"activeCount":100},[],{"trials":262,"activeCount":100},[],{"trials":264,"activeCount":100},[],{"trials":266,"activeCount":100},[],{"trials":268,"activeCount":156,"soonestReadout":273},[269],{"nctId":270,"briefTitle":271,"status":175,"phases":272,"primaryCompletion":273,"completion":273,"start":274,"enrollment":275,"conditions":276,"interventions":277},"NCT06970080","Therapeutic Relevance of Abnormal Airway Morphology in Asthma",[91],"2028-06","2025-06-02",242,[21],[257,278],"Oral Corticosteroid",{"trials":280,"activeCount":100},[],{"intervention":278,"totalTrials":156,"cells":282},{"EARLY_PHASE1":283,"PHASE1":285,"PHASE2":287,"PHASE3":289,"PHASE4":291,"NA":297},{"trials":284,"activeCount":100},[],{"trials":286,"activeCount":100},[],{"trials":288,"activeCount":100},[],{"trials":290,"activeCount":100},[],{"trials":292,"activeCount":156,"soonestReadout":273},[293],{"nctId":270,"briefTitle":271,"status":175,"phases":294,"primaryCompletion":273,"completion":273,"start":274,"enrollment":275,"conditions":295,"interventions":296},[91],[21],[257,278],{"trials":298,"activeCount":100},[],{"intervention":300,"totalTrials":156,"cells":301},"Morphine Sulphate",{"EARLY_PHASE1":302,"PHASE1":304,"PHASE2":306,"PHASE3":308,"PHASE4":310,"NA":329},{"trials":303,"activeCount":100},[],{"trials":305,"activeCount":100},[],{"trials":307,"activeCount":100},[],{"trials":309,"activeCount":100},[],{"trials":311,"activeCount":156,"soonestReadout":316},[312],{"nctId":313,"briefTitle":314,"status":132,"phases":315,"primaryCompletion":316,"completion":317,"start":318,"enrollment":319,"conditions":320,"interventions":325},"NCT07288528","A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough",[91],"2029-04-01","2029-07-01","2026-04-01",124,[321,322,323,324,152],"Cough","Refractory Chronic Cough","Unexplained Chronic Cough","Cough Hypersensitivity Syndrome",[300,326,327,328],"Morphine Sulphate + Cough Control Therapy","Pregabalin","Pregabalin + Cough Control Therapy",{"trials":330,"activeCount":100},[],{"intervention":326,"totalTrials":156,"cells":332},{"EARLY_PHASE1":333,"PHASE1":335,"PHASE2":337,"PHASE3":339,"PHASE4":341,"NA":347},{"trials":334,"activeCount":100},[],{"trials":336,"activeCount":100},[],{"trials":338,"activeCount":100},[],{"trials":340,"activeCount":100},[],{"trials":342,"activeCount":156,"soonestReadout":316},[343],{"nctId":313,"briefTitle":314,"status":132,"phases":344,"primaryCompletion":316,"completion":317,"start":318,"enrollment":319,"conditions":345,"interventions":346},[91],[321,322,323,324,152],[300,326,327,328],{"trials":348,"activeCount":100},[],{"intervention":328,"totalTrials":156,"cells":350},{"EARLY_PHASE1":351,"PHASE1":353,"PHASE2":355,"PHASE3":357,"PHASE4":359,"NA":365},{"trials":352,"activeCount":100},[],{"trials":354,"activeCount":100},[],{"trials":356,"activeCount":100},[],{"trials":358,"activeCount":100},[],{"trials":360,"activeCount":156,"soonestReadout":316},[361],{"nctId":313,"briefTitle":314,"status":132,"phases":362,"primaryCompletion":316,"completion":317,"start":318,"enrollment":319,"conditions":363,"interventions":364},[91],[321,322,323,324,152],[300,326,327,328],{"trials":366,"activeCount":100},[],{"intervention":368,"totalTrials":156,"cells":369},"Celestone + placebo",{"EARLY_PHASE1":370,"PHASE1":372,"PHASE2":374,"PHASE3":376,"PHASE4":378,"NA":396},{"trials":371,"activeCount":100},[],{"trials":373,"activeCount":100},[],{"trials":375,"activeCount":100},[],{"trials":377,"activeCount":100},[],{"trials":379,"activeCount":156,"soonestReadout":384},[380],{"nctId":381,"briefTitle":382,"status":175,"phases":383,"primaryCompletion":384,"completion":385,"start":386,"enrollment":387,"conditions":388,"interventions":394},"NCT05114096","Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)",[91],"2026-12-31","2029-12-31","2023-07-20",3254,[389,390,391,392,393],"Preterm Birth","Premature Birth","Complication of Prematurity","Obstetric Labor, Premature","Pregnancy Complications",[368,395],"Celestone + Celestone",{"trials":397,"activeCount":100},[],{"intervention":395,"totalTrials":156,"cells":399},{"EARLY_PHASE1":400,"PHASE1":402,"PHASE2":404,"PHASE3":406,"PHASE4":408,"NA":414},{"trials":401,"activeCount":100},[],{"trials":403,"activeCount":100},[],{"trials":405,"activeCount":100},[],{"trials":407,"activeCount":100},[],{"trials":409,"activeCount":156,"soonestReadout":384},[410],{"nctId":381,"briefTitle":382,"status":175,"phases":411,"primaryCompletion":384,"completion":385,"start":386,"enrollment":387,"conditions":412,"interventions":413},[91],[389,390,391,392,393],[368,395],{"trials":415,"activeCount":100},[],{"intervention":327,"totalTrials":417,"cells":418},3,{"EARLY_PHASE1":419,"PHASE1":421,"PHASE2":423,"PHASE3":425,"PHASE4":427,"NA":443},{"trials":420,"activeCount":100},[],{"trials":422,"activeCount":100},[],{"trials":424,"activeCount":100},[],{"trials":426,"activeCount":100},[],{"trials":428,"activeCount":156,"soonestReadout":316},[429,439],{"nctId":430,"briefTitle":431,"status":146,"phases":432,"primaryCompletion":433,"completion":433,"start":434,"enrollment":19,"conditions":435,"interventions":437},"NCT00994786","A Study of Pregabalin (Lyrica) Augmentation in Serotonin Reuptake Inhibitor-Refractory Obsessive Compulsive Disorder",[91],"2019-01","2009-01",[436],"Obsessive-Compulsive Disorder",[438],"pregabalin",{"nctId":313,"briefTitle":314,"status":132,"phases":440,"primaryCompletion":316,"completion":317,"start":318,"enrollment":319,"conditions":441,"interventions":442},[91],[321,322,323,324,152],[300,326,327,328],{"trials":444,"activeCount":100},[445],{"nctId":446,"briefTitle":447,"status":448,"phases":449,"primaryCompletion":450,"completion":451,"start":452,"enrollment":24,"conditions":453,"interventions":455},"NCT00891397","Pregabalin Versus Placebo as an Add on for Complex Regional Pain Syndrome (CPRS) of the Upper Limb Managed by Stellate Ganglion Block (The PREGA Study)","TERMINATED",[92],"2010-01","2010-10","2007-11",[454],"Complex Regional Pain Syndromes",[327],{"intervention":141,"totalTrials":417,"cells":457},{"EARLY_PHASE1":458,"PHASE1":460,"PHASE2":462,"PHASE3":464,"PHASE4":466,"NA":472},{"trials":459,"activeCount":100},[],{"trials":461,"activeCount":100},[],{"trials":463,"activeCount":100},[],{"trials":465,"activeCount":100},[],{"trials":467,"activeCount":156,"soonestReadout":134},[468],{"nctId":130,"briefTitle":131,"status":132,"phases":469,"primaryCompletion":134,"completion":135,"start":136,"enrollment":137,"conditions":470,"interventions":471},[91],[139],[141,142],{"trials":473,"activeCount":100},[474,485],{"nctId":475,"briefTitle":476,"status":146,"phases":477,"primaryCompletion":478,"completion":479,"start":480,"enrollment":481,"conditions":482,"interventions":484},"NCT01307215","TAP Block: Does Volume Make a Difference?",[92],"2013-01","2013-03","2011-04",31,[483],"Post-operative Pain",[141,141,141],{"nctId":486,"briefTitle":487,"status":448,"phases":488,"primaryCompletion":489,"completion":490,"start":491,"enrollment":492,"conditions":493,"interventions":496},"NCT04085237","ESP Block for Laparoscopic Nephrectomy Surgeries",[92],"2020-12-31","2023-10-16","2020-01-04",10,[494,495],"Kidney Cancer","Post-surgical Pain",[141],{"intervention":498,"totalTrials":156,"cells":499},"ketamine hydrochloride",{"EARLY_PHASE1":500,"PHASE1":502,"PHASE2":504,"PHASE3":506,"PHASE4":520,"NA":522},{"trials":501,"activeCount":100},[],{"trials":503,"activeCount":100},[],{"trials":505,"activeCount":100},[],{"trials":507,"activeCount":156,"soonestReadout":512},[508],{"nctId":509,"briefTitle":510,"status":132,"phases":511,"primaryCompletion":512,"completion":513,"start":514,"enrollment":515,"conditions":516,"interventions":519},"NCT06767358","Ketamine Sedation in the ICU (KANINE) RCT",[90],"2027-11","2027-12","2025-10",54,[517,518],"Mechanical Ventilation","Critically Ill Intensive Care Unit Patients",[498],{"trials":521,"activeCount":100},[],{"trials":523,"activeCount":100},[],{"intervention":525,"totalTrials":156,"cells":526},"Upadacitinib Oral Product",{"EARLY_PHASE1":527,"PHASE1":529,"PHASE2":531,"PHASE3":533,"PHASE4":546,"NA":548},{"trials":528,"activeCount":100},[],{"trials":530,"activeCount":100},[],{"trials":532,"activeCount":100},[],{"trials":534,"activeCount":156,"soonestReadout":539},[535],{"nctId":536,"briefTitle":537,"status":175,"phases":538,"primaryCompletion":539,"completion":540,"start":541,"enrollment":542,"conditions":543,"interventions":545},"NCT06660693","Comparison of Medical RESCUE Strategies for Patients With Steroid-refractory Acute Severe Ulcerative Colitis",[90],"2027-05","2027-09","2025-04-16",134,[544],"Colitis, Ulcerative",[525],{"trials":547,"activeCount":100},[],{"trials":549,"activeCount":100},[],{"intervention":551,"totalTrials":156,"cells":552},"rivaroxaban and ASA",{"EARLY_PHASE1":553,"PHASE1":555,"PHASE2":557,"PHASE3":559,"PHASE4":577,"NA":579},{"trials":554,"activeCount":100},[],{"trials":556,"activeCount":100},[],{"trials":558,"activeCount":100},[],{"trials":560,"activeCount":156,"soonestReadout":565},[561],{"nctId":562,"briefTitle":563,"status":132,"phases":564,"primaryCompletion":565,"completion":566,"start":567,"enrollment":568,"conditions":569,"interventions":573},"NCT07228663","Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention",[90],"2027-07-01","2027-12-01","2025-12-01",100,[570,571,572],"Hip Fracture Surgery","Cardiovascular Prevention","Venous Thromboembolism (VTE)",[551,574,575,576],"Low-molecular weight heparin","Fondaparinux","Direct Oral Anticoagulant",{"trials":578,"activeCount":100},[],{"trials":580,"activeCount":100},[],{"intervention":574,"totalTrials":156,"cells":582},{"EARLY_PHASE1":583,"PHASE1":585,"PHASE2":587,"PHASE3":589,"PHASE4":595,"NA":597},{"trials":584,"activeCount":100},[],{"trials":586,"activeCount":100},[],{"trials":588,"activeCount":100},[],{"trials":590,"activeCount":156,"soonestReadout":565},[591],{"nctId":562,"briefTitle":563,"status":132,"phases":592,"primaryCompletion":565,"completion":566,"start":567,"enrollment":568,"conditions":593,"interventions":594},[90],[570,571,572],[551,574,575,576],{"trials":596,"activeCount":100},[],{"trials":598,"activeCount":100},[],{"intervention":575,"totalTrials":156,"cells":600},{"EARLY_PHASE1":601,"PHASE1":603,"PHASE2":605,"PHASE3":607,"PHASE4":613,"NA":615},{"trials":602,"activeCount":100},[],{"trials":604,"activeCount":100},[],{"trials":606,"activeCount":100},[],{"trials":608,"activeCount":156,"soonestReadout":565},[609],{"nctId":562,"briefTitle":563,"status":132,"phases":610,"primaryCompletion":565,"completion":566,"start":567,"enrollment":568,"conditions":611,"interventions":612},[90],[570,571,572],[551,574,575,576],{"trials":614,"activeCount":100},[],{"trials":616,"activeCount":100},[],{"intervention":576,"totalTrials":156,"cells":618},{"EARLY_PHASE1":619,"PHASE1":621,"PHASE2":623,"PHASE3":625,"PHASE4":631,"NA":633},{"trials":620,"activeCount":100},[],{"trials":622,"activeCount":100},[],{"trials":624,"activeCount":100},[],{"trials":626,"activeCount":156,"soonestReadout":565},[627],{"nctId":562,"briefTitle":563,"status":132,"phases":628,"primaryCompletion":565,"completion":566,"start":567,"enrollment":568,"conditions":629,"interventions":630},[90],[570,571,572],[551,574,575,576],{"trials":632,"activeCount":100},[],{"trials":634,"activeCount":100},[],{"intervention":636,"totalTrials":637,"cells":638},"Vancomycin",2,{"EARLY_PHASE1":639,"PHASE1":641,"PHASE2":643,"PHASE3":655,"PHASE4":657,"NA":671},{"trials":640,"activeCount":100},[],{"trials":642,"activeCount":100},[],{"trials":644,"activeCount":156,"soonestReadout":248},[645],{"nctId":646,"briefTitle":647,"status":132,"phases":648,"primaryCompletion":248,"completion":649,"start":650,"enrollment":24,"conditions":651,"interventions":654},"NCT07341282","Investigation of Vancomycin Efficacy in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis",[89],"2027-03","2026-01",[652,653],"Ulcerative Colitis (UC)","Primary Sclerosing Cholangitis (PSC)",[636,636],{"trials":656,"activeCount":100},[],{"trials":658,"activeCount":100},[659],{"nctId":660,"briefTitle":661,"status":110,"phases":662,"primaryCompletion":663,"completion":664,"start":665,"enrollment":666,"conditions":667,"interventions":669},"NCT03308253","Study for Antibiotic Impregnated Calcium Sulfate Beads as Prophylaxis for Surgical Site Infection",[91],"2019-06","2019-07","2018-07-16",60,[668],"Surgical Site Infection",[636,670],"Tobramycin",{"trials":672,"activeCount":100},[],{"intervention":674,"totalTrials":637,"cells":675},"Anti-Thymocyte Globulin",{"EARLY_PHASE1":676,"PHASE1":678,"PHASE2":680,"PHASE3":693,"PHASE4":705,"NA":707},{"trials":677,"activeCount":100},[],{"trials":679,"activeCount":100},[],{"trials":681,"activeCount":156,"soonestReadout":50},[682],{"nctId":48,"briefTitle":49,"status":246,"phases":683,"primaryCompletion":50,"completion":684,"start":685,"enrollment":686,"conditions":687,"interventions":691},[89],"2026-02-07","2020-10-14",80,[688,689,690],"Acute Leukemia","Myelodysplasia","Chronic Graft-versus-host-disease",[51,692],"Anti-Thymocyte globulin",{"trials":694,"activeCount":100},[695],{"nctId":696,"briefTitle":697,"status":110,"phases":698,"primaryCompletion":699,"completion":699,"start":700,"enrollment":701,"conditions":702,"interventions":704},"NCT01217723","Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation",[90],"2014-01","2010-04",198,[703],"Hematologic Malignancies",[674],{"trials":706,"activeCount":100},[],{"trials":708,"activeCount":100},[],{"intervention":710,"totalTrials":637,"cells":711},"ChAd-triCoV\u002FMac",{"EARLY_PHASE1":712,"PHASE1":714,"PHASE2":728,"PHASE3":740,"PHASE4":742,"NA":744},{"trials":713,"activeCount":100},[],{"trials":715,"activeCount":100},[716],{"nctId":717,"briefTitle":718,"status":146,"phases":719,"primaryCompletion":720,"completion":55,"start":721,"enrollment":722,"conditions":723,"interventions":726},"NCT05094609","Phase 1 Trial of ChAd68 and Ad5 Adenovirus COVID-19 Vaccines Delivered by Aerosol",[88],"2025-01-15","2022-01-03",36,[724,725],"COVID-19","SARS-CoV2 Infection",[727,710],"Ad5-triCoV\u002FMac",{"trials":729,"activeCount":156,"soonestReadout":248},[730],{"nctId":731,"briefTitle":732,"status":175,"phases":733,"primaryCompletion":248,"completion":734,"start":735,"enrollment":736,"conditions":737,"interventions":739},"NCT06381739","A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol",[89],"2027-01","2025-03-25",350,[738],"COVID-19 Infection",[710],{"trials":741,"activeCount":100},[],{"trials":743,"activeCount":100},[],{"trials":745,"activeCount":100},[],{"intervention":51,"totalTrials":156,"cells":747},{"EARLY_PHASE1":748,"PHASE1":750,"PHASE2":752,"PHASE3":758,"PHASE4":760,"NA":762},{"trials":749,"activeCount":100},[],{"trials":751,"activeCount":100},[],{"trials":753,"activeCount":156,"soonestReadout":50},[754],{"nctId":48,"briefTitle":49,"status":246,"phases":755,"primaryCompletion":50,"completion":684,"start":685,"enrollment":686,"conditions":756,"interventions":757},[89],[688,689,690],[51,692],{"trials":759,"activeCount":100},[],{"trials":761,"activeCount":100},[],{"trials":763,"activeCount":100},[],{"intervention":56,"totalTrials":156,"cells":765},{"EARLY_PHASE1":766,"PHASE1":768,"PHASE2":770,"PHASE3":780,"PHASE4":782,"NA":784},{"trials":767,"activeCount":100},[],{"trials":769,"activeCount":100},[],{"trials":771,"activeCount":156,"soonestReadout":55},[772],{"nctId":53,"briefTitle":54,"status":175,"phases":773,"primaryCompletion":55,"completion":774,"start":775,"enrollment":568,"conditions":776,"interventions":779},[89],"2025-06-28","2024-11-21",[777,778],"Opioid Use","Pain, Postoperative",[56],{"trials":781,"activeCount":100},[],{"trials":783,"activeCount":100},[],{"trials":785,"activeCount":100},[],{"intervention":787,"totalTrials":156,"cells":788},"Psilocybin combined with Psychotherapy",{"EARLY_PHASE1":789,"PHASE1":791,"PHASE2":793,"PHASE3":805,"PHASE4":807,"NA":809},{"trials":790,"activeCount":100},[],{"trials":792,"activeCount":100},[],{"trials":794,"activeCount":156,"soonestReadout":799},[795],{"nctId":796,"briefTitle":797,"status":175,"phases":798,"primaryCompletion":799,"completion":800,"start":60,"enrollment":16,"conditions":801,"interventions":804},"NCT06225232","Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study",[89],"2026-03","2026-06",[802,803],"Cannabis Use Disorder, Moderate","Cannabis Use Disorder, Severe",[787],{"trials":806,"activeCount":100},[],{"trials":808,"activeCount":100},[],{"trials":810,"activeCount":100},[],{"intervention":41,"totalTrials":156,"cells":812},{"EARLY_PHASE1":813,"PHASE1":815,"PHASE2":817,"PHASE3":826,"PHASE4":828,"NA":830},{"trials":814,"activeCount":100},[],{"trials":816,"activeCount":100},[],{"trials":818,"activeCount":156,"soonestReadout":40},[819],{"nctId":38,"briefTitle":39,"status":246,"phases":820,"primaryCompletion":40,"completion":40,"start":821,"enrollment":822,"conditions":823,"interventions":825},[89],"2021-06-01",24,[824],"Ulcerative Colitis Acute",[41],{"trials":827,"activeCount":100},[],{"trials":829,"activeCount":100},[],{"trials":831,"activeCount":100},[],{"intervention":71,"totalTrials":156,"cells":833},{"EARLY_PHASE1":834,"PHASE1":836,"PHASE2":846,"PHASE3":848,"PHASE4":850,"NA":852},{"trials":835,"activeCount":100},[],{"trials":837,"activeCount":156,"soonestReadout":70},[838],{"nctId":68,"briefTitle":69,"status":132,"phases":839,"primaryCompletion":70,"completion":540,"start":840,"enrollment":841,"conditions":842,"interventions":845},[88],"2023-09",40,[843,844],"Urothelial Carcinoma Ureter","Urothelial Cancer of Renal Pelvis",[71],{"trials":847,"activeCount":100},[],{"trials":849,"activeCount":100},[],{"trials":851,"activeCount":100},[],{"trials":853,"activeCount":100},[],{"intervention":855,"totalTrials":156,"cells":856},"Intravenous DNase I",{"EARLY_PHASE1":857,"PHASE1":859,"PHASE2":872,"PHASE3":874,"PHASE4":876,"NA":878},{"trials":858,"activeCount":100},[],{"trials":860,"activeCount":156,"soonestReadout":865},[861],{"nctId":862,"briefTitle":863,"status":175,"phases":864,"primaryCompletion":865,"completion":866,"start":867,"enrollment":722,"conditions":868,"interventions":871},"NCT05453695","Intravenous DNase I for the Treatment of Sepsis (IDEALSepsisI)",[88],"2026-05-28","2026-09-30","2023-01-17",[869,870],"Sepsis","Critical Illness",[855],{"trials":873,"activeCount":100},[],{"trials":875,"activeCount":100},[],{"trials":877,"activeCount":100},[],{"trials":879,"activeCount":100},[],{"intervention":881,"totalTrials":156,"cells":882},"Adenosine 5'-triphosphate",{"EARLY_PHASE1":883,"PHASE1":885,"PHASE2":898,"PHASE3":900,"PHASE4":902,"NA":904},{"trials":884,"activeCount":100},[],{"trials":886,"activeCount":156,"soonestReadout":891},[887],{"nctId":888,"briefTitle":889,"status":175,"phases":890,"primaryCompletion":891,"completion":892,"start":893,"enrollment":894,"conditions":895,"interventions":897},"NCT07085975","The Safety, Feasibility, and Repeatability of Inhaled ATP Cough Challenges",[88],"2026-08-01","2026-10-01","2025-08-05",33,[896,21],"Chronic Cough (CC)",[881],{"trials":899,"activeCount":100},[],{"trials":901,"activeCount":100},[],{"trials":903,"activeCount":100},[],{"trials":905,"activeCount":100},[],{"intervention":46,"totalTrials":156,"cells":907},{"EARLY_PHASE1":908,"PHASE1":910,"PHASE2":921,"PHASE3":923,"PHASE4":925,"NA":927},{"trials":909,"activeCount":100},[],{"trials":911,"activeCount":156,"soonestReadout":45},[912],{"nctId":43,"briefTitle":44,"status":246,"phases":913,"primaryCompletion":45,"completion":914,"start":915,"enrollment":822,"conditions":916,"interventions":920},[88],"2025-03-01","2024-01-11",[917,918,919],"Cannabis","Chronic Kidney Diseases","Dialysis",[46],{"trials":922,"activeCount":100},[],{"trials":924,"activeCount":100},[],{"trials":926,"activeCount":100},[],{"trials":928,"activeCount":100},[],{"intervention":80,"totalTrials":156,"cells":930},{"EARLY_PHASE1":931,"PHASE1":933,"PHASE2":945,"PHASE3":947,"PHASE4":949,"NA":951},{"trials":932,"activeCount":100},[],{"trials":934,"activeCount":156,"soonestReadout":79},[935],{"nctId":77,"briefTitle":78,"status":132,"phases":936,"primaryCompletion":79,"completion":79,"start":937,"enrollment":938,"conditions":939,"interventions":944},[88],"2025-09-15",20,[940,941,942,943],"Healthy Volunteers","Female","Progesterone","Premenopausal",[80],{"trials":946,"activeCount":100},[],{"trials":948,"activeCount":100},[],{"trials":950,"activeCount":100},[],{"trials":952,"activeCount":100},[],{"intervention":954,"totalTrials":156,"cells":955},"Methylprednisolone",{"EARLY_PHASE1":956,"PHASE1":967,"PHASE2":969,"PHASE3":971,"PHASE4":973,"NA":975},{"trials":957,"activeCount":156,"soonestReadout":800},[958],{"nctId":959,"briefTitle":960,"status":132,"phases":961,"primaryCompletion":800,"completion":800,"start":962,"enrollment":938,"conditions":963,"interventions":965},"NCT06081101","Ketorolac Versus Corticosteroid Injections for Sacroiliac Joint Pain",[87],"2025-01",[964],"Sacro-iliac Joint Pain",[954,966],"Ketorolac",{"trials":968,"activeCount":100},[],{"trials":970,"activeCount":100},[],{"trials":972,"activeCount":100},[],{"trials":974,"activeCount":100},[],{"trials":976,"activeCount":100},[],{"intervention":966,"totalTrials":156,"cells":978},{"EARLY_PHASE1":979,"PHASE1":985,"PHASE2":987,"PHASE3":989,"PHASE4":991,"NA":993},{"trials":980,"activeCount":156,"soonestReadout":800},[981],{"nctId":959,"briefTitle":960,"status":132,"phases":982,"primaryCompletion":800,"completion":800,"start":962,"enrollment":938,"conditions":983,"interventions":984},[87],[964],[954,966],{"trials":986,"activeCount":100},[],{"trials":988,"activeCount":100},[],{"trials":990,"activeCount":100},[],{"trials":992,"activeCount":100},[],{"trials":994,"activeCount":100},[],{"intervention":996,"totalTrials":156,"cells":997},"Statin",{"EARLY_PHASE1":998,"PHASE1":1000,"PHASE2":1002,"PHASE3":1004,"PHASE4":1006,"NA":1008},{"trials":999,"activeCount":100},[],{"trials":1001,"activeCount":100},[],{"trials":1003,"activeCount":100},[],{"trials":1005,"activeCount":100},[],{"trials":1007,"activeCount":100},[],{"trials":1009,"activeCount":156,"soonestReadout":248},[1010],{"nctId":1011,"briefTitle":1012,"status":175,"phases":1013,"primaryCompletion":248,"completion":248,"start":1014,"enrollment":1015,"conditions":1016,"interventions":1019},"NCT03127631","A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients",[92],"2015-10-21",6000,[1017,1018],"Prostate Cancer","Cardiovascular Disease",[996,1020],"ACE inhibitor",{"intervention":1020,"totalTrials":156,"cells":1022},{"EARLY_PHASE1":1023,"PHASE1":1025,"PHASE2":1027,"PHASE3":1029,"PHASE4":1031,"NA":1033},{"trials":1024,"activeCount":100},[],{"trials":1026,"activeCount":100},[],{"trials":1028,"activeCount":100},[],{"trials":1030,"activeCount":100},[],{"trials":1032,"activeCount":100},[],{"trials":1034,"activeCount":156,"soonestReadout":248},[1035],{"nctId":1011,"briefTitle":1012,"status":175,"phases":1036,"primaryCompletion":248,"completion":248,"start":1014,"enrollment":1015,"conditions":1037,"interventions":1038},[92],[1017,1018],[996,1020],{"intervention":1040,"totalTrials":156,"cells":1041},"Dual antiplatelet therapy",{"EARLY_PHASE1":1042,"PHASE1":1044,"PHASE2":1046,"PHASE3":1048,"PHASE4":1050,"NA":1052},{"trials":1043,"activeCount":100},[],{"trials":1045,"activeCount":100},[],{"trials":1047,"activeCount":100},[],{"trials":1049,"activeCount":100},[],{"trials":1051,"activeCount":100},[],{"trials":1053,"activeCount":156,"soonestReadout":1058},[1054],{"nctId":1055,"briefTitle":1056,"status":175,"phases":1057,"primaryCompletion":1058,"completion":385,"start":1059,"enrollment":1060,"conditions":1061,"interventions":1064},"NCT05646394","Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS",[],"2029-07-31","2022-07-01",150,[1062,1063],"Antiphospholipid Syndrome","Arterial Thrombosis",[1040,1065,1066,1067],"Combined antithrombotic therapy","Vitamin K antagonist standard intensity","Vitamin K antagonist high intensity",{"intervention":1065,"totalTrials":156,"cells":1069},{"EARLY_PHASE1":1070,"PHASE1":1072,"PHASE2":1074,"PHASE3":1076,"PHASE4":1078,"NA":1080},{"trials":1071,"activeCount":100},[],{"trials":1073,"activeCount":100},[],{"trials":1075,"activeCount":100},[],{"trials":1077,"activeCount":100},[],{"trials":1079,"activeCount":100},[],{"trials":1081,"activeCount":156,"soonestReadout":1058},[1082],{"nctId":1055,"briefTitle":1056,"status":175,"phases":1083,"primaryCompletion":1058,"completion":385,"start":1059,"enrollment":1060,"conditions":1084,"interventions":1085},[],[1062,1063],[1040,1065,1066,1067],{"intervention":1066,"totalTrials":156,"cells":1087},{"EARLY_PHASE1":1088,"PHASE1":1090,"PHASE2":1092,"PHASE3":1094,"PHASE4":1096,"NA":1098},{"trials":1089,"activeCount":100},[],{"trials":1091,"activeCount":100},[],{"trials":1093,"activeCount":100},[],{"trials":1095,"activeCount":100},[],{"trials":1097,"activeCount":100},[],{"trials":1099,"activeCount":156,"soonestReadout":1058},[1100],{"nctId":1055,"briefTitle":1056,"status":175,"phases":1101,"primaryCompletion":1058,"completion":385,"start":1059,"enrollment":1060,"conditions":1102,"interventions":1103},[],[1062,1063],[1040,1065,1066,1067],{"intervention":1067,"totalTrials":156,"cells":1105},{"EARLY_PHASE1":1106,"PHASE1":1108,"PHASE2":1110,"PHASE3":1112,"PHASE4":1114,"NA":1116},{"trials":1107,"activeCount":100},[],{"trials":1109,"activeCount":100},[],{"trials":1111,"activeCount":100},[],{"trials":1113,"activeCount":100},[],{"trials":1115,"activeCount":100},[],{"trials":1117,"activeCount":156,"soonestReadout":1058},[1118],{"nctId":1055,"briefTitle":1056,"status":175,"phases":1119,"primaryCompletion":1058,"completion":385,"start":1059,"enrollment":1060,"conditions":1120,"interventions":1121},[],[1062,1063],[1040,1065,1066,1067],{"intervention":66,"totalTrials":156,"cells":1123},{"EARLY_PHASE1":1124,"PHASE1":1126,"PHASE2":1128,"PHASE3":1130,"PHASE4":1132,"NA":1134},{"trials":1125,"activeCount":100},[],{"trials":1127,"activeCount":100},[],{"trials":1129,"activeCount":100},[],{"trials":1131,"activeCount":100},[],{"trials":1133,"activeCount":100},[],{"trials":1135,"activeCount":156,"soonestReadout":65},[1136],{"nctId":63,"briefTitle":64,"status":175,"phases":1137,"primaryCompletion":65,"completion":1138,"start":1139,"enrollment":1140,"conditions":1141,"interventions":1144},[92],"2025-06-01","2022-12-01",50,[1142,1143],"Tryptophan Metabolism Alterations","Celiac Disease",[66,1145],"Freedom SimpleCap Powder",{"intervention":1145,"totalTrials":156,"cells":1147},{"EARLY_PHASE1":1148,"PHASE1":1150,"PHASE2":1152,"PHASE3":1154,"PHASE4":1156,"NA":1158},{"trials":1149,"activeCount":100},[],{"trials":1151,"activeCount":100},[],{"trials":1153,"activeCount":100},[],{"trials":1155,"activeCount":100},[],{"trials":1157,"activeCount":100},[],{"trials":1159,"activeCount":156,"soonestReadout":65},[1160],{"nctId":63,"briefTitle":64,"status":175,"phases":1161,"primaryCompletion":65,"completion":1138,"start":1139,"enrollment":1140,"conditions":1162,"interventions":1163},[92],[1142,1143],[66,1145],{"intervention":75,"totalTrials":156,"cells":1165},{"EARLY_PHASE1":1166,"PHASE1":1168,"PHASE2":1170,"PHASE3":1172,"PHASE4":1174,"NA":1176},{"trials":1167,"activeCount":100},[],{"trials":1169,"activeCount":100},[],{"trials":1171,"activeCount":100},[],{"trials":1173,"activeCount":100},[],{"trials":1175,"activeCount":100},[],{"trials":1177,"activeCount":156,"soonestReadout":70},[1178],{"nctId":73,"briefTitle":74,"status":246,"phases":1179,"primaryCompletion":70,"completion":1180,"start":1181,"enrollment":1182,"conditions":1183,"interventions":1184},[92],"2025-12","2018-05-01",48,[252],[75],{"intervention":61,"totalTrials":156,"cells":1186},{"EARLY_PHASE1":1187,"PHASE1":1189,"PHASE2":1191,"PHASE3":1193,"PHASE4":1195,"NA":1197},{"trials":1188,"activeCount":100},[],{"trials":1190,"activeCount":100},[],{"trials":1192,"activeCount":100},[],{"trials":1194,"activeCount":100},[],{"trials":1196,"activeCount":100},[],{"trials":1198,"activeCount":156,"soonestReadout":60},[1199],{"nctId":58,"briefTitle":59,"status":175,"phases":1200,"primaryCompletion":60,"completion":1201,"start":1202,"enrollment":1203,"conditions":1204,"interventions":1206},[92],"2025-08","2022-05-27",128,[1205],"COPD",[61],{"intervention":85,"totalTrials":156,"cells":1208},{"EARLY_PHASE1":1209,"PHASE1":1211,"PHASE2":1213,"PHASE3":1215,"PHASE4":1217,"NA":1219},{"trials":1210,"activeCount":100},[],{"trials":1212,"activeCount":100},[],{"trials":1214,"activeCount":100},[],{"trials":1216,"activeCount":100},[],{"trials":1218,"activeCount":100},[],{"trials":1220,"activeCount":156,"soonestReadout":84},[1221],{"nctId":82,"briefTitle":83,"status":175,"phases":1222,"primaryCompletion":84,"completion":84,"start":1223,"enrollment":1224,"conditions":1225,"interventions":1227},[92],"2022-09-02",324,[1226],"Frailty",[85],{"intervention":155,"totalTrials":637,"cells":1229},{"EARLY_PHASE1":1230,"PHASE1":1232,"PHASE2":1234,"PHASE3":1236,"PHASE4":1251,"NA":1257},{"trials":1231,"activeCount":100},[],{"trials":1233,"activeCount":100},[],{"trials":1235,"activeCount":100},[],{"trials":1237,"activeCount":100},[1238],{"nctId":1239,"briefTitle":1240,"status":146,"phases":1241,"primaryCompletion":1242,"completion":1243,"start":1244,"enrollment":1245,"conditions":1246,"interventions":1250},"NCT01463644","Mepolizumab in Chronic Obstructive Pulmonary Diseases (COPD) With Eosinophilic Bronchitis",[90],"2015-08","2015-09","2012-01",18,[1247,1248,1249],"Chronic Obstructive Pulmonary Diseases","Chronic Airways Limitation","Bronchitis",[155],{"trials":1252,"activeCount":100},[1253],{"nctId":144,"briefTitle":145,"status":146,"phases":1254,"primaryCompletion":148,"completion":148,"start":149,"enrollment":150,"conditions":1255,"interventions":1256},[91],[152,153,21],[155,95],{"trials":1258,"activeCount":100},[],{"intervention":1260,"totalTrials":637,"cells":1261},"Oseltamivir",{"EARLY_PHASE1":1262,"PHASE1":1264,"PHASE2":1266,"PHASE3":1268,"PHASE4":1270,"NA":1292},{"trials":1263,"activeCount":100},[],{"trials":1265,"activeCount":100},[],{"trials":1267,"activeCount":100},[],{"trials":1269,"activeCount":100},[],{"trials":1271,"activeCount":100},[1272,1281],{"nctId":1273,"briefTitle":1274,"status":448,"phases":1275,"primaryCompletion":1276,"completion":1276,"start":1277,"enrollment":156,"conditions":1278,"interventions":1280},"NCT02561169","A Trial of Oseltamivir in High-Risk Patients Presenting to the Emergency Department With Influenza",[91],"2016-03","2015-12",[1279],"Influenza",[1260],{"nctId":1282,"briefTitle":1283,"status":1284,"phases":1285,"primaryCompletion":1286,"completion":1286,"start":1287,"enrollment":100,"conditions":1288,"interventions":1290},"NCT02282384","An RCT of Oseltamivir in Outpatients With CPD: A Pilot Study.","WITHDRAWN",[91],"2015-03","2014-10",[1289,1279],"Pulmonary Disease",[1291],"oseltamivir",{"trials":1293,"activeCount":100},[],{"intervention":1295,"totalTrials":637,"cells":1296},"Metformin",{"EARLY_PHASE1":1297,"PHASE1":1299,"PHASE2":1314,"PHASE3":1316,"PHASE4":1318,"NA":1329},{"trials":1298,"activeCount":100},[],{"trials":1300,"activeCount":100},[1301],{"nctId":1302,"briefTitle":1303,"status":1284,"phases":1304,"primaryCompletion":1305,"completion":1306,"start":1307,"enrollment":100,"conditions":1308,"interventions":1312},"NCT03816488","Oral Peri-operative TIming of Metformin (or) Salsalate to Improve Non-cardiac Surgery Glucose Control",[88],"2024-06-01","2024-12-01","2023-12-01",[1309,1310,1311],"Diabetes Mellitus, Type 2","Hyperglycemia","Perioperative\u002FPostoperative Complications",[1295,1313],"Salsalate",{"trials":1315,"activeCount":100},[],{"trials":1317,"activeCount":100},[],{"trials":1319,"activeCount":100},[1320],{"nctId":1321,"briefTitle":1322,"status":1284,"phases":1323,"primaryCompletion":1324,"completion":1324,"start":1325,"enrollment":100,"conditions":1326,"interventions":1328},"NCT02571608","Continuation of Metformin to Improve And Keep Peri-operative Glycemic Control",[91],"2022-12-31","2022-01-01",[1327],"Diabetes Mellitus Type 2",[1295],{"trials":1330,"activeCount":100},[],{"intervention":1332,"totalTrials":637,"cells":1333},"inactivated trivalent influenza vaccine",{"EARLY_PHASE1":1334,"PHASE1":1336,"PHASE2":1338,"PHASE3":1340,"PHASE4":1342,"NA":1363},{"trials":1335,"activeCount":100},[],{"trials":1337,"activeCount":100},[],{"trials":1339,"activeCount":100},[],{"trials":1341,"activeCount":100},[],{"trials":1343,"activeCount":100},[1344,1355],{"nctId":1345,"briefTitle":1346,"status":110,"phases":1347,"primaryCompletion":1348,"completion":1349,"start":1350,"enrollment":1351,"conditions":1352,"interventions":1354},"NCT02762851","Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE)",[91],"2019-12","2020-12","2016-06",5000,[1353,1279],"Heart Failure",[1332],{"nctId":1356,"briefTitle":1357,"status":146,"phases":1358,"primaryCompletion":1277,"completion":1277,"start":1359,"enrollment":1360,"conditions":1361,"interventions":1362},"NCT01945268","Influenza Vaccine To Prevent Adverse Vascular Events:Pilot",[91],"2015-04",107,[1353],[1332],{"trials":1364,"activeCount":100},[],{"intervention":1366,"totalTrials":637,"cells":1367},"Apixaban 2.5 milligram",{"EARLY_PHASE1":1368,"PHASE1":1383,"PHASE2":1385,"PHASE3":1387,"PHASE4":1389,"NA":1405},{"trials":1369,"activeCount":100},[1370],{"nctId":1371,"briefTitle":1372,"status":110,"phases":1373,"primaryCompletion":84,"completion":1374,"start":1375,"enrollment":666,"conditions":1376,"interventions":1382},"NCT03935451","Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease",[87],"2026-02-01","2021-09-01",[1377,29,1378,1379,1380,1381],"IBD","Crohn Disease","Ulcerative Colitis","Pulmonary Embolism","Colorectal Disorders",[1366],{"trials":1384,"activeCount":100},[],{"trials":1386,"activeCount":100},[],{"trials":1388,"activeCount":100},[],{"trials":1390,"activeCount":100},[1391],{"nctId":1392,"briefTitle":1393,"status":146,"phases":1394,"primaryCompletion":1395,"completion":1396,"start":1397,"enrollment":1398,"conditions":1399,"interventions":1404},"NCT04479579","Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery",[91],"2021-10-31","2021-11-06","2021-02-22",53,[1400,1401,29,1402,1403],"Neoplasms Malignant","Surgery","Prophylaxis","Adherence, Medication",[1366],{"trials":1406,"activeCount":100},[],{"intervention":1408,"totalTrials":637,"cells":1409},"L. rhamnosus GG - Probiotic",{"EARLY_PHASE1":1410,"PHASE1":1412,"PHASE2":1414,"PHASE3":1433,"PHASE4":1435,"NA":1451},{"trials":1411,"activeCount":100},[],{"trials":1413,"activeCount":100},[],{"trials":1415,"activeCount":100},[1416],{"nctId":1417,"briefTitle":1418,"status":146,"phases":1419,"primaryCompletion":1420,"completion":1421,"start":1422,"enrollment":1060,"conditions":1423,"interventions":1432},"NCT01782755","Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT): A Feasibility Clinical Trial",[89],"2014-08","2015-01","2013-10",[1424,1425,1426,1427,1428,1429,1430,1431],"Ventilator Associated Pneumonia (VAP)","Other Infections","Antibiotic-Associated Diarrhea","C-Difficile","Duration of Mechanical Ventilation","Length of ICU Stay","Length of Hospital Stay","ICU and Hospital Mortality",[1408],{"trials":1434,"activeCount":100},[],{"trials":1436,"activeCount":100},[1437],{"nctId":1438,"briefTitle":1439,"status":146,"phases":1440,"primaryCompletion":1441,"completion":1442,"start":1443,"enrollment":1444,"conditions":1445,"interventions":1450},"NCT02462590","Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial",[91],"2019-03-13","2020-11-17","2015-06",2650,[1446,1447,1427,1448,1449],"Ventilator Associated Pneumonia","Infections","Antibiotic-associated Diarrhea","Diarrhea",[1408],{"trials":1452,"activeCount":100},[],{"intervention":1454,"totalTrials":637,"cells":1455},"Topiramate",{"EARLY_PHASE1":1456,"PHASE1":1458,"PHASE2":1460,"PHASE3":1462,"PHASE4":1464,"NA":1485},{"trials":1457,"activeCount":100},[],{"trials":1459,"activeCount":100},[],{"trials":1461,"activeCount":100},[],{"trials":1463,"activeCount":100},[],{"trials":1465,"activeCount":100},[1466,1475],{"nctId":1467,"briefTitle":1468,"status":146,"phases":1469,"primaryCompletion":433,"completion":433,"start":1470,"enrollment":1471,"conditions":1472,"interventions":1474},"NCT00182520","Efficacy of Adding Topiramate to Current Treatment in Refractory Obsessive Compulsive Disorder (OCD)",[91],"2002-01",23,[1473],"Obsessive Compulsive Disorder",[1454],{"nctId":1476,"briefTitle":1477,"status":448,"phases":1478,"primaryCompletion":1479,"completion":1479,"start":1480,"enrollment":1481,"conditions":1482,"interventions":1484},"NCT00182455","Efficacy of Adding Topiramate to Current Treatment in Treatment-Resistant Generalized Social Phobia (GSP)",[91],"2018-12-01","2004-03-01",12,[1483],"Social Phobia",[1454],{"trials":1486,"activeCount":100},[],{"intervention":1488,"totalTrials":637,"cells":1489},"Reslizumab",{"EARLY_PHASE1":1490,"PHASE1":1492,"PHASE2":1494,"PHASE3":1496,"PHASE4":1508,"NA":1519},{"trials":1491,"activeCount":100},[],{"trials":1493,"activeCount":100},[],{"trials":1495,"activeCount":100},[],{"trials":1497,"activeCount":100},[1498],{"nctId":1499,"briefTitle":1500,"status":146,"phases":1501,"primaryCompletion":1502,"completion":1503,"start":1504,"enrollment":492,"conditions":1505,"interventions":1507},"NCT02559791","Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma",[89,90],"2017-04","2017-08","2015-10",[1506,153],"Severe Persistent Asthma",[1488],{"trials":1509,"activeCount":100},[1510],{"nctId":1511,"briefTitle":1512,"status":146,"phases":1513,"primaryCompletion":1514,"completion":1514,"start":1515,"enrollment":492,"conditions":1516,"interventions":1518},"NCT04710134","Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma",[91],"2024-01-09","2021-02-10",[1517],"Asthma; Eosinophilic",[1488],{"trials":1520,"activeCount":100},[],{"intervention":1522,"totalTrials":156,"cells":1523},"Adalimumab",{"EARLY_PHASE1":1524,"PHASE1":1526,"PHASE2":1528,"PHASE3":1530,"PHASE4":1532,"NA":1543},{"trials":1525,"activeCount":100},[],{"trials":1527,"activeCount":100},[],{"trials":1529,"activeCount":100},[],{"trials":1531,"activeCount":100},[],{"trials":1533,"activeCount":100},[1534],{"nctId":1535,"briefTitle":1536,"status":1284,"phases":1537,"primaryCompletion":1538,"completion":1539,"start":1540,"enrollment":100,"conditions":1541,"interventions":1542},"NCT03059849","Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD",[91],"2019-02-01","2019-09-01","2018-02-01",[1378,1379],[1522],{"trials":1544,"activeCount":100},[],{"intervention":670,"totalTrials":156,"cells":1546},{"EARLY_PHASE1":1547,"PHASE1":1549,"PHASE2":1551,"PHASE3":1553,"PHASE4":1555,"NA":1561},{"trials":1548,"activeCount":100},[],{"trials":1550,"activeCount":100},[],{"trials":1552,"activeCount":100},[],{"trials":1554,"activeCount":100},[],{"trials":1556,"activeCount":100},[1557],{"nctId":660,"briefTitle":661,"status":110,"phases":1558,"primaryCompletion":663,"completion":664,"start":665,"enrollment":666,"conditions":1559,"interventions":1560},[91],[668],[636,670],{"trials":1562,"activeCount":100},[],{"intervention":1564,"totalTrials":156,"cells":1565},"Methylphenidate Hydrochloride Controlled-Release",{"EARLY_PHASE1":1566,"PHASE1":1568,"PHASE2":1570,"PHASE3":1572,"PHASE4":1574,"NA":1590},{"trials":1567,"activeCount":100},[],{"trials":1569,"activeCount":100},[],{"trials":1571,"activeCount":100},[],{"trials":1573,"activeCount":100},[],{"trials":1575,"activeCount":100},[1576],{"nctId":1577,"briefTitle":1578,"status":146,"phases":1579,"primaryCompletion":1580,"completion":1581,"start":1582,"enrollment":666,"conditions":1583,"interventions":1589},"NCT03785223","A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity",[91],"2022-09-30","2022-10-31","2019-04-20",[1584,1585,1586,1587,1588],"Attention Deficit Hyperactivity Disorder","Generalized Anxiety Disorder","Social Anxiety Disorder","Panic Disorder","Agoraphobia",[1564],{"trials":1591,"activeCount":100},[],{"intervention":1593,"totalTrials":156,"cells":1594},"Simethicone",{"EARLY_PHASE1":1595,"PHASE1":1597,"PHASE2":1599,"PHASE3":1601,"PHASE4":1603,"NA":1615},{"trials":1596,"activeCount":100},[],{"trials":1598,"activeCount":100},[],{"trials":1600,"activeCount":100},[],{"trials":1602,"activeCount":100},[],{"trials":1604,"activeCount":100},[1605],{"nctId":1606,"briefTitle":1607,"status":146,"phases":1608,"primaryCompletion":1609,"completion":1609,"start":1287,"enrollment":568,"conditions":1610,"interventions":1613},"NCT02161367","Effect of Simethicone on Postoperative Ileus in Patients Undergoing Colorectal Surgery",[91],"2015-07",[1611,1612],"Postoperative Ileus","Ileus",[1593,1614],"Oral Suspending Vehicle",{"trials":1616,"activeCount":100},[],{"intervention":1614,"totalTrials":156,"cells":1618},{"EARLY_PHASE1":1619,"PHASE1":1621,"PHASE2":1623,"PHASE3":1625,"PHASE4":1627,"NA":1633},{"trials":1620,"activeCount":100},[],{"trials":1622,"activeCount":100},[],{"trials":1624,"activeCount":100},[],{"trials":1626,"activeCount":100},[],{"trials":1628,"activeCount":100},[1629],{"nctId":1606,"briefTitle":1607,"status":146,"phases":1630,"primaryCompletion":1609,"completion":1609,"start":1287,"enrollment":568,"conditions":1631,"interventions":1632},[91],[1611,1612],[1593,1614],{"trials":1634,"activeCount":100},[],{"intervention":1636,"totalTrials":156,"cells":1637},"Quetiapine Extended Release",{"EARLY_PHASE1":1638,"PHASE1":1640,"PHASE2":1642,"PHASE3":1644,"PHASE4":1646,"NA":1659},{"trials":1639,"activeCount":100},[],{"trials":1641,"activeCount":100},[],{"trials":1643,"activeCount":100},[],{"trials":1645,"activeCount":100},[],{"trials":1647,"activeCount":100},[1648],{"nctId":1649,"briefTitle":1650,"status":146,"phases":1651,"primaryCompletion":1652,"completion":1652,"start":1653,"enrollment":841,"conditions":1654,"interventions":1658},"NCT00723970","Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression",[91],"2009-05","2007-06",[1655,1656,1657],"Major Depressive Disorder","Insomnia","Hot Flashes",[1636],{"trials":1660,"activeCount":100},[],{"intervention":1662,"totalTrials":156,"cells":1663},"MMR",{"EARLY_PHASE1":1664,"PHASE1":1666,"PHASE2":1668,"PHASE3":1670,"PHASE4":1672,"NA":1682},{"trials":1665,"activeCount":100},[],{"trials":1667,"activeCount":100},[],{"trials":1669,"activeCount":100},[],{"trials":1671,"activeCount":100},[],{"trials":1673,"activeCount":100},[1674],{"nctId":1675,"briefTitle":1676,"status":110,"phases":1677,"primaryCompletion":1503,"start":1678,"conditions":1679,"interventions":1680},"NCT02825368","Homeopathic Vaccine Trial",[91],"2016-09",[940],[1662,1681],"Tdap",{"trials":1683,"activeCount":100},[],{"intervention":1681,"totalTrials":156,"cells":1685},{"EARLY_PHASE1":1686,"PHASE1":1688,"PHASE2":1690,"PHASE3":1692,"PHASE4":1694,"NA":1700},{"trials":1687,"activeCount":100},[],{"trials":1689,"activeCount":100},[],{"trials":1691,"activeCount":100},[],{"trials":1693,"activeCount":100},[],{"trials":1695,"activeCount":100},[1696],{"nctId":1675,"briefTitle":1676,"status":110,"phases":1697,"primaryCompletion":1503,"start":1678,"conditions":1698,"interventions":1699},[91],[940],[1662,1681],{"trials":1701,"activeCount":100},[],{"intervention":1703,"totalTrials":156,"cells":1704},"Trivalent Inactivated Vaccine",{"EARLY_PHASE1":1705,"PHASE1":1707,"PHASE2":1709,"PHASE3":1711,"PHASE4":1713,"NA":1724},{"trials":1706,"activeCount":100},[],{"trials":1708,"activeCount":100},[],{"trials":1710,"activeCount":100},[],{"trials":1712,"activeCount":100},[],{"trials":1714,"activeCount":100},[1715],{"nctId":1716,"briefTitle":1717,"status":146,"phases":1718,"primaryCompletion":1443,"completion":1277,"start":1719,"enrollment":1720,"conditions":1721,"interventions":1722},"NCT01653015","Live Versus Inactivated Influenza Vaccine Study in Hutterite Children",[91],"2012-11",4611,[1279],[1703,1723],"Live Attenuated Influenza Vaccine",{"trials":1725,"activeCount":100},[],{"intervention":1723,"totalTrials":156,"cells":1727},{"EARLY_PHASE1":1728,"PHASE1":1730,"PHASE2":1732,"PHASE3":1734,"PHASE4":1736,"NA":1742},{"trials":1729,"activeCount":100},[],{"trials":1731,"activeCount":100},[],{"trials":1733,"activeCount":100},[],{"trials":1735,"activeCount":100},[],{"trials":1737,"activeCount":100},[1738],{"nctId":1716,"briefTitle":1717,"status":146,"phases":1739,"primaryCompletion":1443,"completion":1277,"start":1719,"enrollment":1720,"conditions":1740,"interventions":1741},[91],[1279],[1703,1723],{"trials":1743,"activeCount":100},[],{"intervention":1745,"totalTrials":156,"cells":1746},"Fecal microbiota transplantation",{"EARLY_PHASE1":1747,"PHASE1":1749,"PHASE2":1751,"PHASE3":1753,"PHASE4":1755,"NA":1766},{"trials":1748,"activeCount":100},[],{"trials":1750,"activeCount":100},[],{"trials":1752,"activeCount":100},[],{"trials":1754,"activeCount":100},[],{"trials":1756,"activeCount":100},[1757],{"nctId":1758,"briefTitle":1759,"status":146,"phases":1760,"primaryCompletion":1761,"completion":1761,"start":1762,"enrollment":1763,"conditions":1764,"interventions":1765},"NCT04231110","Combination Therapy With Fecal Microbiota Transplantation and Vedolizumab for Induction of Ulcerative Colitis",[91],"2024-11-18","2021-05-01",6,[1379],[1745],{"trials":1767,"activeCount":100},[],{"intervention":1769,"totalTrials":156,"cells":1770},"Exparel 266 MG Per 20 ML",{"EARLY_PHASE1":1771,"PHASE1":1773,"PHASE2":1775,"PHASE3":1777,"PHASE4":1779,"NA":1791},{"trials":1772,"activeCount":100},[],{"trials":1774,"activeCount":100},[],{"trials":1776,"activeCount":100},[],{"trials":1778,"activeCount":100},[],{"trials":1780,"activeCount":100},[1781],{"nctId":1782,"briefTitle":1783,"status":110,"phases":1784,"primaryCompletion":1785,"completion":1785,"start":1786,"enrollment":686,"conditions":1787,"interventions":1789},"NCT03975283","Use of Exparel for Postoperative Analgesia Following Bariatric Surgery",[91],"2021-08","2019-08",[1788],"Post Operative Pain",[1769,1790],"Bupivacaine Hcl 0.25% Inj",{"trials":1792,"activeCount":100},[],{"intervention":1790,"totalTrials":156,"cells":1794},{"EARLY_PHASE1":1795,"PHASE1":1797,"PHASE2":1799,"PHASE3":1801,"PHASE4":1803,"NA":1809},{"trials":1796,"activeCount":100},[],{"trials":1798,"activeCount":100},[],{"trials":1800,"activeCount":100},[],{"trials":1802,"activeCount":100},[],{"trials":1804,"activeCount":100},[1805],{"nctId":1782,"briefTitle":1783,"status":110,"phases":1806,"primaryCompletion":1785,"completion":1785,"start":1786,"enrollment":686,"conditions":1807,"interventions":1808},[91],[1788],[1769,1790],{"trials":1810,"activeCount":100},[],{"intervention":1812,"totalTrials":156,"cells":1813},"COVID-19 Vaccination",{"EARLY_PHASE1":1814,"PHASE1":1816,"PHASE2":1818,"PHASE3":1820,"PHASE4":1822,"NA":1834},{"trials":1815,"activeCount":100},[],{"trials":1817,"activeCount":100},[],{"trials":1819,"activeCount":100},[],{"trials":1821,"activeCount":100},[],{"trials":1823,"activeCount":100},[1824],{"nctId":1825,"briefTitle":1826,"status":1284,"phases":1827,"primaryCompletion":1828,"completion":1829,"start":1830,"enrollment":100,"conditions":1831,"interventions":1833},"NCT04818736","COVID-19 Vaccine For Indirect Protection",[91],"2021-09","2021-12","2021-04-15",[1832],"Vaccine Preventable Disease",[1812],{"trials":1835,"activeCount":100},[],{"intervention":1837,"totalTrials":156,"cells":1838},"Hepalean Heparin",{"EARLY_PHASE1":1839,"PHASE1":1841,"PHASE2":1843,"PHASE3":1845,"PHASE4":1847,"NA":1860},{"trials":1840,"activeCount":100},[],{"trials":1842,"activeCount":100},[],{"trials":1844,"activeCount":100},[],{"trials":1846,"activeCount":100},[],{"trials":1848,"activeCount":100},[1849],{"nctId":1850,"briefTitle":1851,"status":146,"phases":1852,"primaryCompletion":1853,"completion":1853,"start":1854,"enrollment":1855,"conditions":1856,"interventions":1858},"NCT01343381","Comparison of Heparin Types; Efficacy and Safety",[91],"2011-09","2011-06",21,[1857],"Coronary Artery Disease",[1837,1859],"PPC Heparin",{"trials":1861,"activeCount":100},[],{"intervention":1859,"totalTrials":156,"cells":1863},{"EARLY_PHASE1":1864,"PHASE1":1866,"PHASE2":1868,"PHASE3":1870,"PHASE4":1872,"NA":1878},{"trials":1865,"activeCount":100},[],{"trials":1867,"activeCount":100},[],{"trials":1869,"activeCount":100},[],{"trials":1871,"activeCount":100},[],{"trials":1873,"activeCount":100},[1874],{"nctId":1850,"briefTitle":1851,"status":146,"phases":1875,"primaryCompletion":1853,"completion":1853,"start":1854,"enrollment":1855,"conditions":1876,"interventions":1877},[91],[1857],[1837,1859],{"trials":1879,"activeCount":100},[],{"intervention":1881,"totalTrials":156,"cells":1882},"active clonidine",{"EARLY_PHASE1":1883,"PHASE1":1885,"PHASE2":1887,"PHASE3":1889,"PHASE4":1891,"NA":1904},{"trials":1884,"activeCount":100},[],{"trials":1886,"activeCount":100},[],{"trials":1888,"activeCount":100},[],{"trials":1890,"activeCount":100},[],{"trials":1892,"activeCount":100},[1893],{"nctId":1894,"briefTitle":1895,"status":146,"phases":1896,"primaryCompletion":1897,"completion":450,"start":1652,"enrollment":1898,"conditions":1899,"interventions":1900},"NCT00860925","PeriOperative ISchemic Evaluation-2 Pilot",[91],"2009-12",90,[1018],[1881,1901,1902,1903],"active ASA","Clonidine Placebo","ASA Placebo",{"trials":1905,"activeCount":100},[],{"intervention":1901,"totalTrials":156,"cells":1907},{"EARLY_PHASE1":1908,"PHASE1":1910,"PHASE2":1912,"PHASE3":1914,"PHASE4":1916,"NA":1922},{"trials":1909,"activeCount":100},[],{"trials":1911,"activeCount":100},[],{"trials":1913,"activeCount":100},[],{"trials":1915,"activeCount":100},[],{"trials":1917,"activeCount":100},[1918],{"nctId":1894,"briefTitle":1895,"status":146,"phases":1919,"primaryCompletion":1897,"completion":450,"start":1652,"enrollment":1898,"conditions":1920,"interventions":1921},[91],[1018],[1881,1901,1902,1903],{"trials":1923,"activeCount":100},[],{"intervention":1902,"totalTrials":156,"cells":1925},{"EARLY_PHASE1":1926,"PHASE1":1928,"PHASE2":1930,"PHASE3":1932,"PHASE4":1934,"NA":1940},{"trials":1927,"activeCount":100},[],{"trials":1929,"activeCount":100},[],{"trials":1931,"activeCount":100},[],{"trials":1933,"activeCount":100},[],{"trials":1935,"activeCount":100},[1936],{"nctId":1894,"briefTitle":1895,"status":146,"phases":1937,"primaryCompletion":1897,"completion":450,"start":1652,"enrollment":1898,"conditions":1938,"interventions":1939},[91],[1018],[1881,1901,1902,1903],{"trials":1941,"activeCount":100},[],{"intervention":1903,"totalTrials":156,"cells":1943},{"EARLY_PHASE1":1944,"PHASE1":1946,"PHASE2":1948,"PHASE3":1950,"PHASE4":1952,"NA":1958},{"trials":1945,"activeCount":100},[],{"trials":1947,"activeCount":100},[],{"trials":1949,"activeCount":100},[],{"trials":1951,"activeCount":100},[],{"trials":1953,"activeCount":100},[1954],{"nctId":1894,"briefTitle":1895,"status":146,"phases":1955,"primaryCompletion":1897,"completion":450,"start":1652,"enrollment":1898,"conditions":1956,"interventions":1957},[91],[1018],[1881,1901,1902,1903],{"trials":1959,"activeCount":100},[],{"intervention":1961,"totalTrials":156,"cells":1962},"Vitamin D2",{"EARLY_PHASE1":1963,"PHASE1":1965,"PHASE2":1967,"PHASE3":1969,"PHASE4":1971,"NA":1983},{"trials":1964,"activeCount":100},[],{"trials":1966,"activeCount":100},[],{"trials":1968,"activeCount":100},[],{"trials":1970,"activeCount":100},[],{"trials":1972,"activeCount":100},[1973],{"nctId":1974,"briefTitle":1975,"status":146,"phases":1976,"primaryCompletion":1977,"completion":1977,"start":1978,"enrollment":1979,"conditions":1980,"interventions":1982},"NCT00424619","A Randomised, Controlled Comparison of Vitamin D Strategies is Acute Hip Fracture Patients",[91],"2009-07","2007-10",64,[1981],"Hip Fracture",[1961,1961],{"trials":1984,"activeCount":100},[],{"intervention":1986,"totalTrials":156,"cells":1987},"Alendronate",{"EARLY_PHASE1":1988,"PHASE1":1990,"PHASE2":1992,"PHASE3":1994,"PHASE4":1996,"NA":2010},{"trials":1989,"activeCount":100},[],{"trials":1991,"activeCount":100},[],{"trials":1993,"activeCount":100},[],{"trials":1995,"activeCount":100},[],{"trials":1997,"activeCount":100},[1998],{"nctId":1999,"briefTitle":2000,"status":146,"phases":2001,"primaryCompletion":2002,"completion":2002,"start":2003,"enrollment":2004,"conditions":2005,"interventions":2009},"NCT00157690","Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients",[91],"2006-08","2003-12",56,[2006,2007,2008],"Cystic Fibrosis","Osteoporosis","Bone Diseases, Metabolic",[1986],{"trials":2011,"activeCount":100},[],{"intervention":2013,"totalTrials":156,"cells":2014},"tiotropium bromide",{"EARLY_PHASE1":2015,"PHASE1":2017,"PHASE2":2019,"PHASE3":2021,"PHASE4":2023,"NA":2033},{"trials":2016,"activeCount":100},[],{"trials":2018,"activeCount":100},[],{"trials":2020,"activeCount":100},[],{"trials":2022,"activeCount":100},[],{"trials":2024,"activeCount":100},[2025],{"nctId":2026,"briefTitle":2027,"status":146,"phases":2028,"primaryCompletion":2029,"completion":2029,"start":2030,"enrollment":938,"conditions":2031,"interventions":2032},"NCT00412204","Study to Evaluate the Effects of Tiotropium Bromide on Chronic Obstructive Pulmonary Disease (COPD) During Exercise",[91],"2009-04","2006-06",[1205],[2013],{"trials":2034,"activeCount":100},[],{"intervention":2036,"totalTrials":156,"cells":2037},"Fluad",{"EARLY_PHASE1":2038,"PHASE1":2040,"PHASE2":2042,"PHASE3":2044,"PHASE4":2046,"NA":2057},{"trials":2039,"activeCount":100},[],{"trials":2041,"activeCount":100},[],{"trials":2043,"activeCount":100},[],{"trials":2045,"activeCount":100},[],{"trials":2047,"activeCount":100},[2048],{"nctId":2049,"briefTitle":2050,"status":146,"phases":2051,"primaryCompletion":663,"completion":664,"start":2052,"enrollment":2053,"conditions":2054,"interventions":2055},"NCT02871206","Adjuvanted Inactivated Vaccine Versus Inactivated Influenza Vaccine in Hutterite Children",[91],"2016-11",3425,[1279],[2036,2056],"Fluzone",{"trials":2058,"activeCount":100},[],{"intervention":2056,"totalTrials":156,"cells":2060},{"EARLY_PHASE1":2061,"PHASE1":2063,"PHASE2":2065,"PHASE3":2067,"PHASE4":2069,"NA":2075},{"trials":2062,"activeCount":100},[],{"trials":2064,"activeCount":100},[],{"trials":2066,"activeCount":100},[],{"trials":2068,"activeCount":100},[],{"trials":2070,"activeCount":100},[2071],{"nctId":2049,"briefTitle":2050,"status":146,"phases":2072,"primaryCompletion":663,"completion":664,"start":2052,"enrollment":2053,"conditions":2073,"interventions":2074},[91],[1279],[2036,2056],{"trials":2076,"activeCount":100},[],{"intervention":2078,"totalTrials":156,"cells":2079},"Influenza vaccination",{"EARLY_PHASE1":2080,"PHASE1":2082,"PHASE2":2084,"PHASE3":2086,"PHASE4":2088,"NA":2101},{"trials":2081,"activeCount":100},[],{"trials":2083,"activeCount":100},[],{"trials":2085,"activeCount":100},[],{"trials":2087,"activeCount":100},[],{"trials":2089,"activeCount":100},[2090],{"nctId":2091,"briefTitle":2092,"status":146,"phases":2093,"primaryCompletion":2094,"completion":2095,"start":2096,"enrollment":2097,"conditions":2098,"interventions":2099},"NCT00877396","Hutterite Influenza Prevention Study",[91],"2011-05","2011-07","2008-09",4771,[1279],[2078,2100],"Hepatitis A Vaccine",{"trials":2102,"activeCount":100},[],{"intervention":2100,"totalTrials":156,"cells":2104},{"EARLY_PHASE1":2105,"PHASE1":2107,"PHASE2":2109,"PHASE3":2111,"PHASE4":2113,"NA":2119},{"trials":2106,"activeCount":100},[],{"trials":2108,"activeCount":100},[],{"trials":2110,"activeCount":100},[],{"trials":2112,"activeCount":100},[],{"trials":2114,"activeCount":100},[2115],{"nctId":2091,"briefTitle":2092,"status":146,"phases":2116,"primaryCompletion":2094,"completion":2095,"start":2096,"enrollment":2097,"conditions":2117,"interventions":2118},[91],[1279],[2078,2100],{"trials":2120,"activeCount":100},[],{"intervention":2122,"totalTrials":417,"cells":2123},"Pantoprazole",{"EARLY_PHASE1":2124,"PHASE1":2126,"PHASE2":2128,"PHASE3":2130,"PHASE4":2163,"NA":2165},{"trials":2125,"activeCount":100},[],{"trials":2127,"activeCount":100},[],{"trials":2129,"activeCount":100},[],{"trials":2131,"activeCount":100},[2132,2142,2153],{"nctId":2133,"briefTitle":2134,"status":146,"phases":2135,"primaryCompletion":2136,"start":2137,"enrollment":2138,"conditions":2139,"interventions":2141},"NCT02290327","Re-Evaluating the Inhibition of Stress Erosions: Gastrointestinal Bleeding Prophylaxis In ICU",[90],"2016-01","2015-05",91,[2140],"Stress Ulcer Prophylaxis",[2122],{"nctId":2143,"briefTitle":2144,"status":146,"phases":2145,"primaryCompletion":2146,"completion":2147,"start":2148,"enrollment":2149,"conditions":2150,"interventions":2152},"NCT03374800","Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial",[90],"2023-10-31","2024-01-31","2018-07-09",4800,[2151],"Gastrointestinal Hemorrhage (Clinically Important, Upper)",[2122],{"nctId":2154,"briefTitle":2155,"status":146,"phases":2156,"primaryCompletion":2157,"completion":2157,"start":2158,"enrollment":2159,"conditions":2160,"interventions":2162},"NCT02929563","Pediatric Intensive Care Ulcer Prophylaxis Pilot Trial",[90],"2020-01","2017-01-09",116,[2161],"Gastrointestinal Hemorrhage",[2122],{"trials":2164,"activeCount":100},[],{"trials":2166,"activeCount":100},[],{"intervention":119,"totalTrials":417,"cells":2168},{"EARLY_PHASE1":2169,"PHASE1":2171,"PHASE2":2173,"PHASE3":2175,"PHASE4":2196,"NA":2198},{"trials":2170,"activeCount":100},[],{"trials":2172,"activeCount":100},[],{"trials":2174,"activeCount":100},[],{"trials":2176,"activeCount":100},[2177,2181,2192],{"nctId":108,"briefTitle":109,"status":110,"phases":2178,"primaryCompletion":112,"completion":112,"start":113,"enrollment":114,"conditions":2179,"interventions":2180},[90],[116,117],[119,95],{"nctId":2182,"briefTitle":2183,"status":146,"phases":2184,"primaryCompletion":1504,"completion":2185,"start":2186,"enrollment":568,"conditions":2187,"interventions":2190},"NCT02546648","PeriOperative ISchemic Evaluation-3 Trial: A Pilot Study",[90],"2016-08","2015-02",[2188,2189],"Atherosclerotic Disease","Perioperative Bleeding",[117,2191],"Tranexamic Acid Placebo",{"nctId":121,"briefTitle":122,"status":110,"phases":2193,"primaryCompletion":112,"completion":112,"start":113,"enrollment":114,"conditions":2194,"interventions":2195},[90],[116,125,117],[119,95],{"trials":2197,"activeCount":100},[],{"trials":2199,"activeCount":100},[],{"intervention":2201,"totalTrials":637,"cells":2202},"Benralizumab",{"EARLY_PHASE1":2203,"PHASE1":2205,"PHASE2":2207,"PHASE3":2227,"PHASE4":2239,"NA":2241},{"trials":2204,"activeCount":100},[],{"trials":2206,"activeCount":100},[],{"trials":2208,"activeCount":100},[2209],{"nctId":2210,"briefTitle":2211,"status":146,"phases":2212,"primaryCompletion":2213,"completion":2213,"start":2214,"enrollment":938,"conditions":2215,"interventions":2226},"NCT03563066","Effect of Benralizumab in Atopic Dermatitis",[89],"2021-09-28","2018-09-04",[2216,2217,2218,2219,2220,2221,2222,2223,2224,2225],"Dermatitis, Atopic","Dermatitis","Eczema","Skin Diseases","Skin Diseases, Genetic","Genetic Diseases, Inborn","Skin Diseases, Eczematous","Hypersensitivity","Hypersensitivity, Immediate","Immune System Diseases",[2201],{"trials":2228,"activeCount":100},[2229],{"nctId":2230,"briefTitle":2231,"status":146,"phases":2232,"primaryCompletion":2233,"completion":2234,"start":2235,"enrollment":938,"conditions":2236,"interventions":2238},"NCT03470311","Benralizumab in Patients With Inadequate Response to Anti-IL5 Monoclonal Antibody Therapies",[90],"2022-06-14","2022-11-30","2018-04-26",[2237],"Severe Prednisone Dependent Eosinophilic Asthma",[2201],{"trials":2240,"activeCount":100},[],{"trials":2242,"activeCount":100},[],{"intervention":2244,"totalTrials":637,"cells":2245},"Tezepelumab",{"EARLY_PHASE1":2246,"PHASE1":2248,"PHASE2":2250,"PHASE3":2262,"PHASE4":2274,"NA":2276},{"trials":2247,"activeCount":100},[],{"trials":2249,"activeCount":100},[],{"trials":2251,"activeCount":100},[2252],{"nctId":2253,"briefTitle":2254,"status":110,"phases":2255,"primaryCompletion":2256,"completion":2256,"start":2257,"enrollment":2258,"conditions":2259,"interventions":2261},"NCT05740748","Tezepelumab and Methacholine Airway Hyperresponsiveness in Participants With Mild Allergic Asthma",[89],"2024-12-30","2023-04-01",34,[2260],"Asthma, Allergic",[2244],{"trials":2263,"activeCount":100},[2264],{"nctId":2265,"briefTitle":2266,"status":146,"phases":2267,"primaryCompletion":2268,"completion":2269,"start":2270,"enrollment":2271,"conditions":2272,"interventions":2273},"NCT05280418","Tezepelumab on Airway Structure and Function in Patients With Uncontrolled Moderate-to-severe Asthma",[90],"2025-11-05","2025-12-17","2022-11-08",27,[21],[2244],{"trials":2275,"activeCount":100},[],{"trials":2277,"activeCount":100},[],{"intervention":2279,"totalTrials":637,"cells":2280},"Rivaroxaban",{"EARLY_PHASE1":2281,"PHASE1":2283,"PHASE2":2285,"PHASE3":2287,"PHASE4":2307,"NA":2309},{"trials":2282,"activeCount":100},[],{"trials":2284,"activeCount":100},[],{"trials":2286,"activeCount":100},[],{"trials":2288,"activeCount":100},[2289,2299],{"nctId":2290,"briefTitle":2291,"status":146,"phases":2292,"primaryCompletion":2293,"completion":2293,"start":2294,"enrollment":2295,"conditions":2296,"interventions":2298},"NCT02123524","Rivaroxaban Anticoagulation for Superficial Vein Thrombosis",[90],"2018-12-03","2014-11-11",85,[2297],"Symptomatic Superficial Vein Thrombosis",[2279],{"nctId":2300,"briefTitle":2301,"status":448,"phases":2302,"primaryCompletion":1609,"completion":1609,"start":478,"enrollment":2303,"conditions":2304,"interventions":2306},"NCT01598168","Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia",[90],22,[2305],"Heparin-induced Thrombocytopenia",[2279],{"trials":2308,"activeCount":100},[],{"trials":2310,"activeCount":100},[],{"intervention":2312,"totalTrials":637,"cells":2313},"Caffeine citrate",{"EARLY_PHASE1":2314,"PHASE1":2316,"PHASE2":2318,"PHASE3":2320,"PHASE4":2342,"NA":2344},{"trials":2315,"activeCount":100},[],{"trials":2317,"activeCount":100},[],{"trials":2319,"activeCount":100},[],{"trials":2321,"activeCount":100},[2322,2332],{"nctId":2323,"briefTitle":2324,"status":146,"phases":2325,"primaryCompletion":2326,"completion":2326,"start":2327,"enrollment":2328,"conditions":2329,"interventions":2331},"NCT01020357","Caffeine for Apnea of Prematurity-Sleep (CAP-S) Study",[90],"2013-07","2009-11",201,[2330],"Apnea of Prematurity",[2312],{"nctId":2333,"briefTitle":2334,"status":146,"phases":2335,"primaryCompletion":2336,"completion":2337,"start":2338,"enrollment":2339,"conditions":2340,"interventions":2341},"NCT00182312","Caffeine for Apnea of Prematurity (CAP)",[90],"2007-03","2016-07","1999-10",2000,[2330],[2312],{"trials":2343,"activeCount":100},[],{"trials":2345,"activeCount":100},[],{"intervention":2347,"totalTrials":156,"cells":2348},"LMWH",{"EARLY_PHASE1":2349,"PHASE1":2351,"PHASE2":2353,"PHASE3":2355,"PHASE4":2368,"NA":2370},{"trials":2350,"activeCount":100},[],{"trials":2352,"activeCount":100},[],{"trials":2354,"activeCount":100},[],{"trials":2356,"activeCount":100},[2357],{"nctId":2358,"briefTitle":2359,"status":146,"phases":2360,"primaryCompletion":2361,"completion":2361,"start":2362,"enrollment":2363,"conditions":2364,"interventions":2366},"NCT00182143","PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)",[90],"2010-06","2006-05",3659,[870,2365],"Deep Venous Thrombosis",[2347,2367],"Unfractionated Heparin",{"trials":2369,"activeCount":100},[],{"trials":2371,"activeCount":100},[],{"intervention":2367,"totalTrials":156,"cells":2373},{"EARLY_PHASE1":2374,"PHASE1":2376,"PHASE2":2378,"PHASE3":2380,"PHASE4":2386,"NA":2388},{"trials":2375,"activeCount":100},[],{"trials":2377,"activeCount":100},[],{"trials":2379,"activeCount":100},[],{"trials":2381,"activeCount":100},[2382],{"nctId":2358,"briefTitle":2359,"status":146,"phases":2383,"primaryCompletion":2361,"completion":2361,"start":2362,"enrollment":2363,"conditions":2384,"interventions":2385},[90],[870,2365],[2347,2367],{"trials":2387,"activeCount":100},[],{"trials":2389,"activeCount":100},[],{"intervention":2391,"totalTrials":156,"cells":2392},"Intraoperative Intravenous Lidocaine",{"EARLY_PHASE1":2393,"PHASE1":2395,"PHASE2":2397,"PHASE3":2399,"PHASE4":2413,"NA":2415},{"trials":2394,"activeCount":100},[],{"trials":2396,"activeCount":100},[],{"trials":2398,"activeCount":100},[],{"trials":2400,"activeCount":100},[2401],{"nctId":2402,"briefTitle":2403,"status":146,"phases":2404,"primaryCompletion":2136,"completion":2136,"start":2405,"enrollment":568,"conditions":2406,"interventions":2409},"NCT02240199","Perioperative Pregabalin and Lidocaine to Reduce Chronic Breast Cancer Pain",[90],"2014-11",[2407,2408],"Post-mastectomy Pain Syndrome","Chronic Post-surgical Pain",[2391,2410,2411,2412],"Perioperative Pregabalin","Perioperative Pregabalin Placebo","Intraoperative Intravenous Lidocaine Placebo",{"trials":2414,"activeCount":100},[],{"trials":2416,"activeCount":100},[],{"intervention":2410,"totalTrials":156,"cells":2418},{"EARLY_PHASE1":2419,"PHASE1":2421,"PHASE2":2423,"PHASE3":2425,"PHASE4":2431,"NA":2433},{"trials":2420,"activeCount":100},[],{"trials":2422,"activeCount":100},[],{"trials":2424,"activeCount":100},[],{"trials":2426,"activeCount":100},[2427],{"nctId":2402,"briefTitle":2403,"status":146,"phases":2428,"primaryCompletion":2136,"completion":2136,"start":2405,"enrollment":568,"conditions":2429,"interventions":2430},[90],[2407,2408],[2391,2410,2411,2412],{"trials":2432,"activeCount":100},[],{"trials":2434,"activeCount":100},[],{"intervention":2411,"totalTrials":156,"cells":2436},{"EARLY_PHASE1":2437,"PHASE1":2439,"PHASE2":2441,"PHASE3":2443,"PHASE4":2449,"NA":2451},{"trials":2438,"activeCount":100},[],{"trials":2440,"activeCount":100},[],{"trials":2442,"activeCount":100},[],{"trials":2444,"activeCount":100},[2445],{"nctId":2402,"briefTitle":2403,"status":146,"phases":2446,"primaryCompletion":2136,"completion":2136,"start":2405,"enrollment":568,"conditions":2447,"interventions":2448},[90],[2407,2408],[2391,2410,2411,2412],{"trials":2450,"activeCount":100},[],{"trials":2452,"activeCount":100},[],{"intervention":2412,"totalTrials":156,"cells":2454},{"EARLY_PHASE1":2455,"PHASE1":2457,"PHASE2":2459,"PHASE3":2461,"PHASE4":2467,"NA":2469},{"trials":2456,"activeCount":100},[],{"trials":2458,"activeCount":100},[],{"trials":2460,"activeCount":100},[],{"trials":2462,"activeCount":100},[2463],{"nctId":2402,"briefTitle":2403,"status":146,"phases":2464,"primaryCompletion":2136,"completion":2136,"start":2405,"enrollment":568,"conditions":2465,"interventions":2466},[90],[2407,2408],[2391,2410,2411,2412],{"trials":2468,"activeCount":100},[],{"trials":2470,"activeCount":100},[],{"intervention":2472,"totalTrials":156,"cells":2473},"12 mg betamethasone + placebo",{"EARLY_PHASE1":2474,"PHASE1":2476,"PHASE2":2478,"PHASE3":2480,"PHASE4":2493,"NA":2495},{"trials":2475,"activeCount":100},[],{"trials":2477,"activeCount":100},[],{"trials":2479,"activeCount":100},[],{"trials":2481,"activeCount":100},[2482],{"nctId":2483,"briefTitle":2484,"status":146,"phases":2485,"primaryCompletion":2486,"completion":2486,"start":2487,"enrollment":2488,"conditions":2489,"interventions":2491},"NCT04494529","Single Dose Antenatal Corticosteroids (SNACS) for Women at Risk of Preterm Birth",[90],"2021-08-31","2021-03-01",30,[389,391,392,2490,393],"Obstetric Labor Complications",[2472,2492],"24 mg betamethasone",{"trials":2494,"activeCount":100},[],{"trials":2496,"activeCount":100},[],{"intervention":2492,"totalTrials":156,"cells":2498},{"EARLY_PHASE1":2499,"PHASE1":2501,"PHASE2":2503,"PHASE3":2505,"PHASE4":2511,"NA":2513},{"trials":2500,"activeCount":100},[],{"trials":2502,"activeCount":100},[],{"trials":2504,"activeCount":100},[],{"trials":2506,"activeCount":100},[2507],{"nctId":2483,"briefTitle":2484,"status":146,"phases":2508,"primaryCompletion":2486,"completion":2486,"start":2487,"enrollment":2488,"conditions":2509,"interventions":2510},[90],[389,391,392,2490,393],[2472,2492],{"trials":2512,"activeCount":100},[],{"trials":2514,"activeCount":100},[],{"intervention":2516,"totalTrials":156,"cells":2517},"Haloperidol",{"EARLY_PHASE1":2518,"PHASE1":2520,"PHASE2":2522,"PHASE3":2524,"PHASE4":2535,"NA":2537},{"trials":2519,"activeCount":100},[],{"trials":2521,"activeCount":100},[],{"trials":2523,"activeCount":100},[],{"trials":2525,"activeCount":100},[2526],{"nctId":2527,"briefTitle":2528,"status":146,"phases":2529,"primaryCompletion":1243,"completion":2337,"start":2530,"enrollment":2531,"conditions":2532,"interventions":2534},"NCT01862302","Haloperidol Prophylaxis in Cardiac Surgery for Patients at Risk for Delirium",[90],"2013-08",25,[2533],"Postoperative Confusion",[2516],{"trials":2536,"activeCount":100},[],{"trials":2538,"activeCount":100},[],{"intervention":2540,"totalTrials":156,"cells":2541},"collagenase",{"EARLY_PHASE1":2542,"PHASE1":2544,"PHASE2":2546,"PHASE3":2548,"PHASE4":2559,"NA":2561},{"trials":2543,"activeCount":100},[],{"trials":2545,"activeCount":100},[],{"trials":2547,"activeCount":100},[],{"trials":2549,"activeCount":100},[2550],{"nctId":2551,"briefTitle":2552,"status":146,"phases":2553,"primaryCompletion":2554,"completion":2554,"start":2555,"enrollment":2303,"conditions":2556,"interventions":2558},"NCT02725528","Evaluation of Xiaflex: Trial of Effectivenss iN Dupuytren's",[90],"2021-12-17","2017-07-08",[2557],"Dupuytren's Disease",[2540],{"trials":2560,"activeCount":100},[],{"trials":2562,"activeCount":100},[],{"intervention":2564,"totalTrials":156,"cells":2565},"Becaplermin",{"EARLY_PHASE1":2566,"PHASE1":2568,"PHASE2":2570,"PHASE3":2572,"PHASE4":2584,"NA":2586},{"trials":2567,"activeCount":100},[],{"trials":2569,"activeCount":100},[],{"trials":2571,"activeCount":100},[],{"trials":2573,"activeCount":100},[2574],{"nctId":2575,"briefTitle":2576,"status":110,"phases":2577,"primaryCompletion":2578,"completion":2578,"start":2579,"enrollment":686,"conditions":2580,"interventions":2583},"NCT02845466","Study of Combined Topical Growth Factor and Protease Inhibitor in Chronic Wound Healing",[90],"2020-09","2018-08",[2581,2582],"Venous Ulcer","Foot Ulcer, Diabetic",[2564],{"trials":2585,"activeCount":100},[],{"trials":2587,"activeCount":100},[],{"intervention":2589,"totalTrials":156,"cells":2590},"MPL-001",{"EARLY_PHASE1":2591,"PHASE1":2593,"PHASE2":2595,"PHASE3":2597,"PHASE4":2608,"NA":2610},{"trials":2592,"activeCount":100},[],{"trials":2594,"activeCount":100},[],{"trials":2596,"activeCount":100},[],{"trials":2598,"activeCount":100},[2599],{"nctId":2600,"briefTitle":2601,"status":146,"phases":2602,"primaryCompletion":2603,"completion":2603,"start":2604,"enrollment":2605,"conditions":2606,"interventions":2607},"NCT03825965","Cannabinoids vs. Placebo on Persistent Post-surgical Pain Following TKA: A Pilot RCT",[90],"2025-02-25","2023-05-03",39,[35],[2589],{"trials":2609,"activeCount":100},[],{"trials":2611,"activeCount":100},[],{"intervention":2613,"totalTrials":156,"cells":2614},"50:2 mg",{"EARLY_PHASE1":2615,"PHASE1":2617,"PHASE2":2619,"PHASE3":2621,"PHASE4":2632,"NA":2634},{"trials":2616,"activeCount":100},[],{"trials":2618,"activeCount":100},[],{"trials":2620,"activeCount":100},[],{"trials":2622,"activeCount":100},[2623],{"nctId":2624,"briefTitle":2625,"status":1284,"phases":2626,"primaryCompletion":2627,"completion":2628,"start":2629,"enrollment":100,"conditions":2630,"interventions":2631},"NCT04569760","Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study",[90],"2023-04","2023-06","2021-04",[1585,1586,1587,1588],[2613],{"trials":2633,"activeCount":100},[],{"trials":2635,"activeCount":100},[],{"intervention":2191,"totalTrials":156,"cells":2637},{"EARLY_PHASE1":2638,"PHASE1":2640,"PHASE2":2642,"PHASE3":2644,"PHASE4":2650,"NA":2652},{"trials":2639,"activeCount":100},[],{"trials":2641,"activeCount":100},[],{"trials":2643,"activeCount":100},[],{"trials":2645,"activeCount":100},[2646],{"nctId":2182,"briefTitle":2183,"status":146,"phases":2647,"primaryCompletion":1504,"completion":2185,"start":2186,"enrollment":568,"conditions":2648,"interventions":2649},[90],[2188,2189],[117,2191],{"trials":2651,"activeCount":100},[],{"trials":2653,"activeCount":100},[],{"intervention":2655,"totalTrials":156,"cells":2656},"Vitamin D",{"EARLY_PHASE1":2657,"PHASE1":2659,"PHASE2":2661,"PHASE3":2663,"PHASE4":2675,"NA":2677},{"trials":2658,"activeCount":100},[],{"trials":2660,"activeCount":100},[],{"trials":2662,"activeCount":100},[],{"trials":2664,"activeCount":100},[2665],{"nctId":2666,"briefTitle":2667,"status":448,"phases":2668,"primaryCompletion":2669,"completion":2669,"start":2670,"enrollment":2138,"conditions":2671,"interventions":2673},"NCT01908751","Fixation Using Alternative Implants for the Treatment of Hip Fractures (FAITH-2)",[90],"2019-03-18","2014-09",[2672],"Femoral Neck Fractures",[2655,2674],"Vitamin D Placebo",{"trials":2676,"activeCount":100},[],{"trials":2678,"activeCount":100},[],{"intervention":2674,"totalTrials":156,"cells":2680},{"EARLY_PHASE1":2681,"PHASE1":2683,"PHASE2":2685,"PHASE3":2687,"PHASE4":2693,"NA":2695},{"trials":2682,"activeCount":100},[],{"trials":2684,"activeCount":100},[],{"trials":2686,"activeCount":100},[],{"trials":2688,"activeCount":100},[2689],{"nctId":2666,"briefTitle":2667,"status":448,"phases":2690,"primaryCompletion":2669,"completion":2669,"start":2670,"enrollment":2138,"conditions":2691,"interventions":2692},[90],[2672],[2655,2674],{"trials":2694,"activeCount":100},[],{"trials":2696,"activeCount":100},[],{"intervention":2698,"totalTrials":156,"cells":2699},"Fidaxomicin",{"EARLY_PHASE1":2700,"PHASE1":2702,"PHASE2":2704,"PHASE3":2706,"PHASE4":2716,"NA":2718},{"trials":2701,"activeCount":100},[],{"trials":2703,"activeCount":100},[],{"trials":2705,"activeCount":100},[],{"trials":2707,"activeCount":100},[2708],{"nctId":2709,"briefTitle":2710,"status":448,"phases":2711,"primaryCompletion":2712,"completion":2712,"start":1609,"enrollment":481,"conditions":2713,"interventions":2715},"NCT02395848","Efficacy of 30-day Duration of Fidaxomicin for Recurrent C. Difficile Infection",[90],"2021-08-30",[2714],"Clostridium Difficile Infection",[2698],{"trials":2717,"activeCount":100},[],{"trials":2719,"activeCount":100},[],{"intervention":2721,"totalTrials":156,"cells":2722},"UFH 250 U\u002Fkg or LMWH 100 U\u002Fkg sc twice daily",{"EARLY_PHASE1":2723,"PHASE1":2725,"PHASE2":2727,"PHASE3":2729,"PHASE4":2741,"NA":2743},{"trials":2724,"activeCount":100},[],{"trials":2726,"activeCount":100},[],{"trials":2728,"activeCount":100},[],{"trials":2730,"activeCount":100},[2731],{"nctId":2732,"briefTitle":2733,"status":146,"phases":2734,"completion":2735,"start":2736,"enrollment":2737,"conditions":2738,"interventions":2740},"NCT00182403","Fixed Dose Heparin Study",[90],"2004-05","1998-09",866,[29,2739,1380],"Deep Vein Thrombosis",[2721],{"trials":2742,"activeCount":100},[],{"trials":2744,"activeCount":100},[],{"intervention":2746,"totalTrials":156,"cells":2747},"Metronidazole and Rifampin",{"EARLY_PHASE1":2748,"PHASE1":2750,"PHASE2":2752,"PHASE3":2754,"PHASE4":2769,"NA":2771},{"trials":2749,"activeCount":100},[],{"trials":2751,"activeCount":100},[],{"trials":2753,"activeCount":100},[],{"trials":2755,"activeCount":100},[2756],{"nctId":2757,"briefTitle":2758,"status":146,"phases":2759,"primaryCompletion":2760,"completion":2761,"start":2762,"enrollment":568,"conditions":2763,"interventions":2768},"NCT00182429","Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment",[90],"2005-04-30","2005-12-31","2004-02",[2764,1426,2765,2766,2767],"Clostridium Enterocolitis","Pseudomembranous Colitis","Pseudomembranous Enterocolitis","Pseudomembranous Enteritis",[2746],{"trials":2770,"activeCount":100},[],{"trials":2772,"activeCount":100},[],{"intervention":2774,"totalTrials":156,"cells":2775},"Tamsulosin Hydrochloride",{"EARLY_PHASE1":2776,"PHASE1":2778,"PHASE2":2780,"PHASE3":2782,"PHASE4":2796,"NA":2798},{"trials":2777,"activeCount":100},[],{"trials":2779,"activeCount":100},[],{"trials":2781,"activeCount":100},[],{"trials":2783,"activeCount":100},[2784],{"nctId":2785,"briefTitle":2786,"status":110,"phases":2787,"primaryCompletion":2788,"completion":2788,"start":2789,"enrollment":736,"conditions":2790,"interventions":2794},"NCT04159077","REduction of Post-Operative Urinary Retention With Tamsulosin Versus Placebo (REPOURT- P) Trial",[90],"2023-12-31","2021-07-30",[2791,2792,2793],"Urinary Catheterization","Thoracic Surgery","Thoracic Epidural Analgesia",[2774,2795],"Placebos",{"trials":2797,"activeCount":100},[],{"trials":2799,"activeCount":100},[],{"intervention":2795,"totalTrials":156,"cells":2801},{"EARLY_PHASE1":2802,"PHASE1":2804,"PHASE2":2806,"PHASE3":2808,"PHASE4":2814,"NA":2816},{"trials":2803,"activeCount":100},[],{"trials":2805,"activeCount":100},[],{"trials":2807,"activeCount":100},[],{"trials":2809,"activeCount":100},[2810],{"nctId":2785,"briefTitle":2786,"status":110,"phases":2811,"primaryCompletion":2788,"completion":2788,"start":2789,"enrollment":736,"conditions":2812,"interventions":2813},[90],[2791,2792,2793],[2774,2795],{"trials":2815,"activeCount":100},[],{"trials":2817,"activeCount":100},[],{"intervention":2819,"totalTrials":156,"cells":2820},"Dupilumab\u002FDupixent",{"EARLY_PHASE1":2821,"PHASE1":2823,"PHASE2":2825,"PHASE3":2827,"PHASE4":2837,"NA":2839},{"trials":2822,"activeCount":100},[],{"trials":2824,"activeCount":100},[],{"trials":2826,"activeCount":100},[],{"trials":2828,"activeCount":100},[2829],{"nctId":2830,"briefTitle":2831,"status":146,"phases":2832,"primaryCompletion":2833,"completion":867,"start":2834,"enrollment":822,"conditions":2835,"interventions":2836},"NCT03884842","Dupilumab on Airway Hyper-responsiveness and Ventilation Heterogeneity in Patients With Asthma.",[90],"2022-10-12","2019-07-01",[21],[2819],{"trials":2838,"activeCount":100},[],{"trials":2840,"activeCount":100},[],{"intervention":2842,"totalTrials":156,"cells":2843},"Tapered warfarin regimen",{"EARLY_PHASE1":2844,"PHASE1":2846,"PHASE2":2848,"PHASE3":2850,"PHASE4":2866,"NA":2868},{"trials":2845,"activeCount":100},[],{"trials":2847,"activeCount":100},[],{"trials":2849,"activeCount":100},[],{"trials":2851,"activeCount":100},[2852],{"nctId":2853,"briefTitle":2854,"status":448,"phases":2855,"primaryCompletion":2856,"completion":2857,"start":2858,"enrollment":2859,"conditions":2860,"interventions":2864},"NCT02094157","Tapered Warfarin or Interrupted Warfarin With Heparin Bridging for Pacemaker or Defibrillator Implantation",[90],"2013-11","2014-03","2007-12",173,[2861,2862,2863],"Cardiac Arrhythmias","Hemorrhage","Thromboembolism",[2842,2865],"Bridged regimen Low-molecular-weight heparin",{"trials":2867,"activeCount":100},[],{"trials":2869,"activeCount":100},[],{"intervention":2865,"totalTrials":156,"cells":2871},{"EARLY_PHASE1":2872,"PHASE1":2874,"PHASE2":2876,"PHASE3":2878,"PHASE4":2884,"NA":2886},{"trials":2873,"activeCount":100},[],{"trials":2875,"activeCount":100},[],{"trials":2877,"activeCount":100},[],{"trials":2879,"activeCount":100},[2880],{"nctId":2853,"briefTitle":2854,"status":448,"phases":2881,"primaryCompletion":2856,"completion":2857,"start":2858,"enrollment":2859,"conditions":2882,"interventions":2883},[90],[2861,2862,2863],[2842,2865],{"trials":2885,"activeCount":100},[],{"trials":2887,"activeCount":100},[],{"intervention":2889,"totalTrials":156,"cells":2890},"24-Hour Prophylactic Cefazolin* Antibiotic Regimen",{"EARLY_PHASE1":2891,"PHASE1":2893,"PHASE2":2895,"PHASE3":2897,"PHASE4":2910,"NA":2912},{"trials":2892,"activeCount":100},[],{"trials":2894,"activeCount":100},[],{"trials":2896,"activeCount":100},[],{"trials":2898,"activeCount":100},[2899],{"nctId":2900,"briefTitle":2901,"status":146,"phases":2902,"primaryCompletion":2903,"completion":2903,"start":478,"enrollment":2904,"conditions":2905,"interventions":2908},"NCT01479283","Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY)",[90],"2021-03",602,[2906,2907],"Infection","Bone Neoplasms",[2889,2909],"5-Days Prophylactic Cefazolin* Antibiotic Regimen",{"trials":2911,"activeCount":100},[],{"trials":2913,"activeCount":100},[],{"intervention":2909,"totalTrials":156,"cells":2915},{"EARLY_PHASE1":2916,"PHASE1":2918,"PHASE2":2920,"PHASE3":2922,"PHASE4":2928,"NA":2930},{"trials":2917,"activeCount":100},[],{"trials":2919,"activeCount":100},[],{"trials":2921,"activeCount":100},[],{"trials":2923,"activeCount":100},[2924],{"nctId":2900,"briefTitle":2901,"status":146,"phases":2925,"primaryCompletion":2903,"completion":2903,"start":478,"enrollment":2904,"conditions":2926,"interventions":2927},[90],[2906,2907],[2889,2909],{"trials":2929,"activeCount":100},[],{"trials":2931,"activeCount":100},[],{"intervention":2933,"totalTrials":156,"cells":2934},"Telmisartan (Micardis®) vs. Placebo",{"EARLY_PHASE1":2935,"PHASE1":2937,"PHASE2":2939,"PHASE3":2941,"PHASE4":2954,"NA":2956},{"trials":2936,"activeCount":100},[],{"trials":2938,"activeCount":100},[],{"trials":2940,"activeCount":100},[],{"trials":2942,"activeCount":100},[2943],{"nctId":2944,"briefTitle":2945,"status":146,"phases":2946,"primaryCompletion":2947,"completion":2948,"start":2949,"enrollment":2950,"conditions":2951,"interventions":2953},"NCT00147264","Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial",[90],"2006-01","2006-11","2004-04",120,[2952],"Metabolic Syndrome X",[2933],{"trials":2955,"activeCount":100},[],{"trials":2957,"activeCount":100},[],{"intervention":2959,"totalTrials":156,"cells":2960},"doxycycline",{"EARLY_PHASE1":2961,"PHASE1":2963,"PHASE2":2965,"PHASE3":2967,"PHASE4":2980,"NA":2982},{"trials":2962,"activeCount":100},[],{"trials":2964,"activeCount":100},[],{"trials":2966,"activeCount":100},[],{"trials":2968,"activeCount":100},[2969],{"nctId":2970,"briefTitle":2971,"status":110,"phases":2972,"primaryCompletion":2973,"completion":2974,"start":2975,"enrollment":1855,"conditions":2976,"interventions":2978},"NCT00715858","A Pilot Study of Inflammatory Markers in Alzheimer's Disease",[90],"2009-08","2009-10","2008-05",[2977],"Alzheimer's Disease",[2959,2979],"rifampin",{"trials":2981,"activeCount":100},[],{"trials":2983,"activeCount":100},[],{"intervention":2979,"totalTrials":156,"cells":2985},{"EARLY_PHASE1":2986,"PHASE1":2988,"PHASE2":2990,"PHASE3":2992,"PHASE4":2998,"NA":3000},{"trials":2987,"activeCount":100},[],{"trials":2989,"activeCount":100},[],{"trials":2991,"activeCount":100},[],{"trials":2993,"activeCount":100},[2994],{"nctId":2970,"briefTitle":2971,"status":110,"phases":2995,"primaryCompletion":2973,"completion":2974,"start":2975,"enrollment":1855,"conditions":2996,"interventions":2997},[90],[2977],[2959,2979],{"trials":2999,"activeCount":100},[],{"trials":3001,"activeCount":100},[],{"intervention":3003,"totalTrials":156,"cells":3004},"Eltrombopag",{"EARLY_PHASE1":3005,"PHASE1":3007,"PHASE2":3009,"PHASE3":3011,"PHASE4":3022,"NA":3024},{"trials":3006,"activeCount":100},[],{"trials":3008,"activeCount":100},[],{"trials":3010,"activeCount":100},[],{"trials":3012,"activeCount":100},[3013],{"nctId":3014,"briefTitle":3015,"status":146,"phases":3016,"primaryCompletion":663,"completion":1786,"start":3017,"enrollment":179,"conditions":3018,"interventions":3020},"NCT01621204","A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients",[90],"2012-10",[3019],"Immune Thrombocytopenic Purpura",[3003,3021],"IVIG",{"trials":3023,"activeCount":100},[],{"trials":3025,"activeCount":100},[],{"intervention":3021,"totalTrials":156,"cells":3027},{"EARLY_PHASE1":3028,"PHASE1":3030,"PHASE2":3032,"PHASE3":3034,"PHASE4":3040,"NA":3042},{"trials":3029,"activeCount":100},[],{"trials":3031,"activeCount":100},[],{"trials":3033,"activeCount":100},[],{"trials":3035,"activeCount":100},[3036],{"nctId":3014,"briefTitle":3015,"status":146,"phases":3037,"primaryCompletion":663,"completion":1786,"start":3017,"enrollment":179,"conditions":3038,"interventions":3039},[90],[3019],[3003,3021],{"trials":3041,"activeCount":100},[],{"trials":3043,"activeCount":100},[],{"intervention":3045,"totalTrials":156,"cells":3046},"Cannabidiol (CBD) Oil",{"EARLY_PHASE1":3047,"PHASE1":3049,"PHASE2":3051,"PHASE3":3053,"PHASE4":3065,"NA":3067},{"trials":3048,"activeCount":100},[],{"trials":3050,"activeCount":100},[],{"trials":3052,"activeCount":100},[],{"trials":3054,"activeCount":100},[3055],{"nctId":3056,"briefTitle":3057,"status":110,"phases":3058,"primaryCompletion":3059,"completion":3060,"start":3061,"enrollment":1140,"conditions":3062,"interventions":3063},"NCT03549819","Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study",[90],"2023-12-15","2024-02","2021-12-15",[1585,1586,1587,1588],[3045,3064],"Sunflower Lecithin Oil in",{"trials":3066,"activeCount":100},[],{"trials":3068,"activeCount":100},[],{"intervention":3064,"totalTrials":156,"cells":3070},{"EARLY_PHASE1":3071,"PHASE1":3073,"PHASE2":3075,"PHASE3":3077,"PHASE4":3083,"NA":3085},{"trials":3072,"activeCount":100},[],{"trials":3074,"activeCount":100},[],{"trials":3076,"activeCount":100},[],{"trials":3078,"activeCount":100},[3079],{"nctId":3056,"briefTitle":3057,"status":110,"phases":3080,"primaryCompletion":3059,"completion":3060,"start":3061,"enrollment":1140,"conditions":3081,"interventions":3082},[90],[1585,1586,1587,1588],[3045,3064],{"trials":3084,"activeCount":100},[],{"trials":3086,"activeCount":100},[],{"intervention":3088,"totalTrials":156,"cells":3089},"Omalizumab",{"EARLY_PHASE1":3090,"PHASE1":3092,"PHASE2":3094,"PHASE3":3096,"PHASE4":3106,"NA":3108},{"trials":3091,"activeCount":100},[],{"trials":3093,"activeCount":100},[],{"trials":3095,"activeCount":100},[],{"trials":3097,"activeCount":100},[3098],{"nctId":3099,"briefTitle":3100,"status":146,"phases":3101,"primaryCompletion":3102,"completion":3102,"start":2857,"enrollment":30,"conditions":3103,"interventions":3105},"NCT02049294","Study of the Steroid Sparing Effect of Xolair (Omalizumab) in Patients With Persistent Eosinophilic Bronchitis",[89,90],"2017-09",[3104,153],"Steroid and\u002For Prednisone Dependent Asthma",[3088],{"trials":3107,"activeCount":100},[],{"trials":3109,"activeCount":100},[],{"intervention":3111,"totalTrials":156,"cells":3112},"Fresh FMT",{"EARLY_PHASE1":3113,"PHASE1":3115,"PHASE2":3117,"PHASE3":3128,"PHASE4":3130,"NA":3132},{"trials":3114,"activeCount":100},[],{"trials":3116,"activeCount":100},[],{"trials":3118,"activeCount":100},[3119],{"nctId":3120,"briefTitle":3121,"status":146,"phases":3122,"primaryCompletion":1421,"completion":1286,"start":3123,"enrollment":3124,"conditions":3125,"interventions":3126},"NCT01398969","Multi-Centre Trial of Fresh vs. Frozen-and-Thawed FMT for Recurrent CDI",[89],"2012-07",232,[2714],[3111,3127],"Frozen-and-Thawed FMT",{"trials":3129,"activeCount":100},[],{"trials":3131,"activeCount":100},[],{"trials":3133,"activeCount":100},[],{"intervention":3127,"totalTrials":156,"cells":3135},{"EARLY_PHASE1":3136,"PHASE1":3138,"PHASE2":3140,"PHASE3":3146,"PHASE4":3148,"NA":3150},{"trials":3137,"activeCount":100},[],{"trials":3139,"activeCount":100},[],{"trials":3141,"activeCount":100},[3142],{"nctId":3120,"briefTitle":3121,"status":146,"phases":3143,"primaryCompletion":1421,"completion":1286,"start":3123,"enrollment":3124,"conditions":3144,"interventions":3145},[89],[2714],[3111,3127],{"trials":3147,"activeCount":100},[],{"trials":3149,"activeCount":100},[],{"trials":3151,"activeCount":100},[],{"intervention":3153,"totalTrials":156,"cells":3154},"Naproxen",{"EARLY_PHASE1":3155,"PHASE1":3157,"PHASE2":3159,"PHASE3":3172,"PHASE4":3174,"NA":3176},{"trials":3156,"activeCount":100},[],{"trials":3158,"activeCount":100},[],{"trials":3160,"activeCount":100},[3161],{"nctId":3162,"briefTitle":3163,"status":448,"phases":3164,"primaryCompletion":3165,"completion":3165,"start":3166,"enrollment":3167,"conditions":3168,"interventions":3171},"NCT01612975","The Effect of Non-Steroidal Anti-Inflammatory Drug Naproxen on Pleural Effusion Formation After Lung Resection",[89],"2018-01","2014-04",7,[3169,3170],"Pleural Effusion","Pleural Effusion Malignant",[3153],{"trials":3173,"activeCount":100},[],{"trials":3175,"activeCount":100},[],{"trials":3177,"activeCount":100},[],{"intervention":3179,"totalTrials":156,"cells":3180},"Double dose",{"EARLY_PHASE1":3181,"PHASE1":3183,"PHASE2":3185,"PHASE3":3197,"PHASE4":3199,"NA":3201},{"trials":3182,"activeCount":100},[],{"trials":3184,"activeCount":100},[],{"trials":3186,"activeCount":100},[3187],{"nctId":3188,"briefTitle":3189,"status":146,"phases":3190,"primaryCompletion":3191,"completion":3191,"start":480,"enrollment":3192,"conditions":3193,"interventions":3196},"NCT01348074","Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist",[89],"2013-12",104,[3194,29,3195,1401],"Atrial Fibrillation","Heart Valve Disease",[3179],{"trials":3198,"activeCount":100},[],{"trials":3200,"activeCount":100},[],{"trials":3202,"activeCount":100},[],{"intervention":3204,"totalTrials":156,"cells":3205},"SH-DS01 + Metronidazole",{"EARLY_PHASE1":3206,"PHASE1":3208,"PHASE2":3210,"PHASE3":3223,"PHASE4":3225,"NA":3227},{"trials":3207,"activeCount":100},[],{"trials":3209,"activeCount":100},[],{"trials":3211,"activeCount":100},[3212],{"nctId":3213,"briefTitle":3214,"status":1284,"phases":3215,"primaryCompletion":3216,"completion":3217,"start":3218,"enrollment":100,"conditions":3219,"interventions":3222},"NCT04955574","Probiotic and Antibiotic Therapies in Women With Unexplained Infertility",[89],"2024-01","2024-12","2023-01",[3220,3221],"Unexplained Infertility","Endometriosis",[3204],{"trials":3224,"activeCount":100},[],{"trials":3226,"activeCount":100},[],{"trials":3228,"activeCount":100},[],{"intervention":3230,"totalTrials":156,"cells":3231},"LMWH: Dalteparin",{"EARLY_PHASE1":3232,"PHASE1":3234,"PHASE2":3236,"PHASE3":3247,"PHASE4":3249,"NA":3251},{"trials":3233,"activeCount":100},[],{"trials":3235,"activeCount":100},[],{"trials":3237,"activeCount":100},[3238],{"nctId":3239,"briefTitle":3240,"status":146,"phases":3241,"primaryCompletion":3242,"completion":3242,"start":1243,"enrollment":3243,"conditions":3244,"interventions":3246},"NCT02334007","Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery",[88,89],"2018-09",102,[29,3245,1380],"Lung Neoplasms",[3230],{"trials":3248,"activeCount":100},[],{"trials":3250,"activeCount":100},[],{"trials":3252,"activeCount":100},[],{"intervention":3254,"totalTrials":156,"cells":3255},"OZURDEX",{"EARLY_PHASE1":3256,"PHASE1":3258,"PHASE2":3260,"PHASE3":3271,"PHASE4":3273,"NA":3275},{"trials":3257,"activeCount":100},[],{"trials":3259,"activeCount":100},[],{"trials":3261,"activeCount":100},[3262],{"nctId":3263,"briefTitle":3264,"status":146,"phases":3265,"primaryCompletion":2137,"completion":2137,"start":3266,"enrollment":492,"conditions":3267,"interventions":3269},"NCT01243086","OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab",[89],"2011-03",[3268],"Wet Macular Degeneration",[3270,3254],"Ranibizumab",{"trials":3272,"activeCount":100},[],{"trials":3274,"activeCount":100},[],{"trials":3276,"activeCount":100},[],{"intervention":3278,"totalTrials":156,"cells":3279},"Oxytocin",{"EARLY_PHASE1":3280,"PHASE1":3282,"PHASE2":3284,"PHASE3":3295,"PHASE4":3297,"NA":3299},{"trials":3281,"activeCount":100},[],{"trials":3283,"activeCount":100},[],{"trials":3285,"activeCount":100},[3286],{"nctId":3287,"briefTitle":3288,"status":448,"phases":3289,"primaryCompletion":2095,"completion":2095,"start":700,"enrollment":3290,"conditions":3291,"interventions":3294},"NCT00890630","Intracervical Catheters for Induction of Labour in Women With Prelabour Rupture of Membranes at Term",[89],5,[3292,3293],"Fetal Membranes, Premature Rupture","Induced Labor",[3278],{"trials":3296,"activeCount":100},[],{"trials":3298,"activeCount":100},[],{"trials":3300,"activeCount":100},[],{"intervention":3302,"totalTrials":156,"cells":3303},"Apixaban",{"EARLY_PHASE1":3304,"PHASE1":3306,"PHASE2":3308,"PHASE3":3321,"PHASE4":3323,"NA":3325},{"trials":3305,"activeCount":100},[],{"trials":3307,"activeCount":100},[],{"trials":3309,"activeCount":100},[3310],{"nctId":3311,"briefTitle":3312,"status":448,"phases":3313,"primaryCompletion":2834,"completion":3314,"start":3315,"enrollment":3316,"conditions":3317,"interventions":3319},"NCT03200613","Apixaban For Thromboprophylaxis In Patients With Acute Spinal Cord Injury",[89],"2019-08-01","2017-09-01",8,[3318,29],"Spinal Cord Injuries",[3302,3320],"Low molecular weight heparin",{"trials":3322,"activeCount":100},[],{"trials":3324,"activeCount":100},[],{"trials":3326,"activeCount":100},[],{"intervention":3320,"totalTrials":156,"cells":3328},{"EARLY_PHASE1":3329,"PHASE1":3331,"PHASE2":3333,"PHASE3":3339,"PHASE4":3341,"NA":3343},{"trials":3330,"activeCount":100},[],{"trials":3332,"activeCount":100},[],{"trials":3334,"activeCount":100},[3335],{"nctId":3311,"briefTitle":3312,"status":448,"phases":3336,"primaryCompletion":2834,"completion":3314,"start":3315,"enrollment":3316,"conditions":3337,"interventions":3338},[89],[3318,29],[3302,3320],{"trials":3340,"activeCount":100},[],{"trials":3342,"activeCount":100},[],{"trials":3344,"activeCount":100},[],{"intervention":3346,"totalTrials":156,"cells":3347},"Fecal Microbiota Transplant",{"EARLY_PHASE1":3348,"PHASE1":3350,"PHASE2":3352,"PHASE3":3365,"PHASE4":3367,"NA":3369},{"trials":3349,"activeCount":100},[],{"trials":3351,"activeCount":100},[],{"trials":3353,"activeCount":100},[3354],{"nctId":3355,"briefTitle":3356,"status":448,"phases":3357,"primaryCompletion":3358,"completion":3359,"start":3360,"enrollment":3361,"conditions":3362,"interventions":3364},"NCT02394275","A Prospective Trial of Frozen-and-Thawed Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection",[89],"2016-09-01","2019-10-31","2014-03-01",140,[3363],"Clostridium Difficile",[3346],{"trials":3366,"activeCount":100},[],{"trials":3368,"activeCount":100},[],{"trials":3370,"activeCount":100},[],{"intervention":3372,"totalTrials":156,"cells":3373},"Sodium Chloride 0.9% Inhl 3Ml",{"EARLY_PHASE1":3374,"PHASE1":3376,"PHASE2":3378,"PHASE3":3389,"PHASE4":3391,"NA":3393},{"trials":3375,"activeCount":100},[],{"trials":3377,"activeCount":100},[],{"trials":3379,"activeCount":100},[3380],{"nctId":3381,"briefTitle":3382,"status":146,"phases":3383,"primaryCompletion":3384,"completion":3384,"start":3385,"enrollment":938,"conditions":3386,"interventions":3387},"NCT04565847","The Effects of Salbutamol on Mannitol Induced Cough Responses in Healthy Controls",[89],"2021-12-16","2020-11-30",[321],[3388,3372],"Salbutamol 5mg\u002FmL",{"trials":3390,"activeCount":100},[],{"trials":3392,"activeCount":100},[],{"trials":3394,"activeCount":100},[],{"intervention":3396,"totalTrials":156,"cells":3397},"0.75% bupivacaine",{"EARLY_PHASE1":3398,"PHASE1":3400,"PHASE2":3402,"PHASE3":3413,"PHASE4":3415,"NA":3417},{"trials":3399,"activeCount":100},[],{"trials":3401,"activeCount":100},[],{"trials":3403,"activeCount":100},[3404],{"nctId":3405,"briefTitle":3406,"status":1284,"phases":3407,"primaryCompletion":3408,"completion":3408,"start":1359,"enrollment":100,"conditions":3409,"interventions":3412},"NCT03266081","Bupivacaine Epiphora Trial",[89],"2022-08-23",[3410,3411],"Epiphora","Ptosis",[3396],{"trials":3414,"activeCount":100},[],{"trials":3416,"activeCount":100},[],{"trials":3418,"activeCount":100},[],{"intervention":3420,"totalTrials":637,"cells":3421},"Ad5Ag85A",{"EARLY_PHASE1":3422,"PHASE1":3424,"PHASE2":3443,"PHASE3":3445,"PHASE4":3447,"NA":3449},{"trials":3423,"activeCount":100},[],{"trials":3425,"activeCount":100},[3426,3435],{"nctId":3427,"briefTitle":3428,"status":448,"phases":3429,"primaryCompletion":3430,"completion":2326,"start":3431,"enrollment":822,"conditions":3432,"interventions":3434},"NCT00800670","Study of the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine",[88],"2012-12","2009-06",[3433],"Tuberculosis",[3420,3420],{"nctId":3436,"briefTitle":3437,"status":146,"phases":3438,"primaryCompletion":3439,"completion":3439,"start":3440,"enrollment":722,"conditions":3441,"interventions":3442},"NCT02337270","Phase 1 Clinical Trial of the Safety and Immunogenicity of an Adenovirus-based TB Vaccine Administered by Aerosol",[88],"2021-09-07","2017-09-05",[3433],[3420],{"trials":3444,"activeCount":100},[],{"trials":3446,"activeCount":100},[],{"trials":3448,"activeCount":100},[],{"trials":3450,"activeCount":100},[],{"intervention":1313,"totalTrials":156,"cells":3452},{"EARLY_PHASE1":3453,"PHASE1":3455,"PHASE2":3461,"PHASE3":3463,"PHASE4":3465,"NA":3467},{"trials":3454,"activeCount":100},[],{"trials":3456,"activeCount":100},[3457],{"nctId":1302,"briefTitle":1303,"status":1284,"phases":3458,"primaryCompletion":1305,"completion":1306,"start":1307,"enrollment":100,"conditions":3459,"interventions":3460},[88],[1309,1310,1311],[1295,1313],{"trials":3462,"activeCount":100},[],{"trials":3464,"activeCount":100},[],{"trials":3466,"activeCount":100},[],{"trials":3468,"activeCount":100},[],{"intervention":3470,"totalTrials":156,"cells":3471},"Benzodiazepine - limited use strategy",{"EARLY_PHASE1":3472,"PHASE1":3474,"PHASE2":3487,"PHASE3":3489,"PHASE4":3491,"NA":3493},{"trials":3473,"activeCount":100},[],{"trials":3475,"activeCount":100},[3476],{"nctId":3477,"briefTitle":3478,"status":146,"phases":3479,"primaryCompletion":3480,"completion":3480,"start":3481,"enrollment":3482,"conditions":3483,"interventions":3485},"NCT03053869","Benzodiazepine-free Anesthetic for Reduction of Delirium (B-Free)",[88],"2018-09-30","2017-04-01",480,[3484],"Post-operative Delirium",[3470,3486],"Benzodiazepine - Ad libitum strategy",{"trials":3488,"activeCount":100},[],{"trials":3490,"activeCount":100},[],{"trials":3492,"activeCount":100},[],{"trials":3494,"activeCount":100},[],{"intervention":3486,"totalTrials":156,"cells":3496},{"EARLY_PHASE1":3497,"PHASE1":3499,"PHASE2":3505,"PHASE3":3507,"PHASE4":3509,"NA":3511},{"trials":3498,"activeCount":100},[],{"trials":3500,"activeCount":100},[3501],{"nctId":3477,"briefTitle":3478,"status":146,"phases":3502,"primaryCompletion":3480,"completion":3480,"start":3481,"enrollment":3482,"conditions":3503,"interventions":3504},[88],[3484],[3470,3486],{"trials":3506,"activeCount":100},[],{"trials":3508,"activeCount":100},[],{"trials":3510,"activeCount":100},[],{"trials":3512,"activeCount":100},[],{"intervention":727,"totalTrials":156,"cells":3514},{"EARLY_PHASE1":3515,"PHASE1":3517,"PHASE2":3523,"PHASE3":3525,"PHASE4":3527,"NA":3529},{"trials":3516,"activeCount":100},[],{"trials":3518,"activeCount":100},[3519],{"nctId":717,"briefTitle":718,"status":146,"phases":3520,"primaryCompletion":720,"completion":55,"start":721,"enrollment":722,"conditions":3521,"interventions":3522},[88],[724,725],[727,710],{"trials":3524,"activeCount":100},[],{"trials":3526,"activeCount":100},[],{"trials":3528,"activeCount":100},[],{"trials":3530,"activeCount":100},[],{"intervention":3532,"totalTrials":156,"cells":3533},"Estring Vaginal Ring",{"EARLY_PHASE1":3534,"PHASE1":3536,"PHASE2":3547,"PHASE3":3549,"PHASE4":3551,"NA":3553},{"trials":3535,"activeCount":100},[],{"trials":3537,"activeCount":100},[3538],{"nctId":3539,"briefTitle":3540,"status":146,"phases":3541,"primaryCompletion":149,"completion":149,"start":3542,"enrollment":1140,"conditions":3543,"interventions":3546},"NCT03837015","Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women",[88],"2019-11-04",[3544,3545],"HIV-1-infection","Bacterial Vaginoses",[3532],{"trials":3548,"activeCount":100},[],{"trials":3550,"activeCount":100},[],{"trials":3552,"activeCount":100},[],{"trials":3554,"activeCount":100},[],{"intervention":3556,"totalTrials":156,"cells":3557},"Progressive Perfect Probiotic",{"EARLY_PHASE1":3558,"PHASE1":3560,"PHASE2":3571,"PHASE3":3573,"PHASE4":3575,"NA":3577},{"trials":3559,"activeCount":100},[],{"trials":3561,"activeCount":100},[3562],{"nctId":3563,"briefTitle":3564,"status":110,"phases":3565,"primaryCompletion":3566,"completion":3566,"start":3216,"enrollment":841,"conditions":3567,"interventions":3570},"NCT06213428","Effects of Probiotics on Synaptic Plasticity During the Menstrual Cycle",[88],"2025-05",[3568,3569],"Women's Health","Brain Plasticity",[3556],{"trials":3572,"activeCount":100},[],{"trials":3574,"activeCount":100},[],{"trials":3576,"activeCount":100},[],{"trials":3578,"activeCount":100},[],{"intervention":3580,"totalTrials":156,"cells":3581},"Red blood cells",{"EARLY_PHASE1":3582,"PHASE1":3594,"PHASE2":3596,"PHASE3":3598,"PHASE4":3600,"NA":3602},{"trials":3583,"activeCount":100},[3584],{"nctId":3585,"briefTitle":3586,"status":146,"phases":3587,"primaryCompletion":1202,"completion":3588,"start":3589,"enrollment":3590,"conditions":3591,"interventions":3593},"NCT04814264","Pilot Study of Sex-matched vs. Sex-mismatched Red Blood Cell Transfusion",[87],"2023-02-28","2022-01-07",270,[3592],"Blood Transfusion",[3580],{"trials":3595,"activeCount":100},[],{"trials":3597,"activeCount":100},[],{"trials":3599,"activeCount":100},[],{"trials":3601,"activeCount":100},[],{"trials":3603,"activeCount":100},[],{"intervention":3605,"totalTrials":156,"cells":3606},"17β-estradiol",{"EARLY_PHASE1":3607,"PHASE1":3620,"PHASE2":3622,"PHASE3":3624,"PHASE4":3626,"NA":3628},{"trials":3608,"activeCount":100},[3609],{"nctId":3610,"briefTitle":3611,"status":1284,"phases":3612,"primaryCompletion":3613,"completion":3614,"start":3615,"enrollment":100,"conditions":3616,"interventions":3618},"NCT03069781","The Effects of 17β-estradiol on Skeletal Muscle",[87],"2018-05","2018-08-14","2017-05",[3617],"Muscle Atrophy",[3605,3619],"Polycose",{"trials":3621,"activeCount":100},[],{"trials":3623,"activeCount":100},[],{"trials":3625,"activeCount":100},[],{"trials":3627,"activeCount":100},[],{"trials":3629,"activeCount":100},[],{"intervention":3619,"totalTrials":156,"cells":3631},{"EARLY_PHASE1":3632,"PHASE1":3638,"PHASE2":3640,"PHASE3":3642,"PHASE4":3644,"NA":3646},{"trials":3633,"activeCount":100},[3634],{"nctId":3610,"briefTitle":3611,"status":1284,"phases":3635,"primaryCompletion":3613,"completion":3614,"start":3615,"enrollment":100,"conditions":3636,"interventions":3637},[87],[3617],[3605,3619],{"trials":3639,"activeCount":100},[],{"trials":3641,"activeCount":100},[],{"trials":3643,"activeCount":100},[],{"trials":3645,"activeCount":100},[],{"trials":3647,"activeCount":100},[],{"intervention":3649,"totalTrials":156,"cells":3650},"Multi-nutrient supplement",{"EARLY_PHASE1":3651,"PHASE1":3664,"PHASE2":3666,"PHASE3":3668,"PHASE4":3670,"NA":3672},{"trials":3652,"activeCount":100},[3653],{"nctId":3654,"briefTitle":3655,"status":110,"phases":3656,"primaryCompletion":3657,"completion":3657,"start":3658,"enrollment":2488,"conditions":3659,"interventions":3663},"NCT04781868","Multi-Nutrient Supplement for Radio-Protection",[87],"2025-07-01","2024-07-01",[3660,3661,3662],"Oxidative Stress","DNA Damage, Radiation Induced","Radiation Exposure",[3649],{"trials":3665,"activeCount":100},[],{"trials":3667,"activeCount":100},[],{"trials":3669,"activeCount":100},[],{"trials":3671,"activeCount":100},[],{"trials":3673,"activeCount":100},[],{"intervention":3675,"totalTrials":156,"cells":3676},"Low Dose Lidocaine",{"EARLY_PHASE1":3677,"PHASE1":3689,"PHASE2":3691,"PHASE3":3693,"PHASE4":3695,"NA":3697},{"trials":3678,"activeCount":100},[3679],{"nctId":3680,"briefTitle":3681,"status":1284,"phases":3682,"primaryCompletion":3683,"completion":3684,"start":1828,"enrollment":100,"conditions":3685,"interventions":3687},"NCT03095404","Intravenous Lidocaine for Post-Operative Pain Control in Patients Undergoing Bariatric Bowel Surgery",[87],"2021-12-31","2022-02-28",[3686],"Bariatric Surgery Candidate",[3675,3688],"High Dose Lidocaine",{"trials":3690,"activeCount":100},[],{"trials":3692,"activeCount":100},[],{"trials":3694,"activeCount":100},[],{"trials":3696,"activeCount":100},[],{"trials":3698,"activeCount":100},[],{"intervention":3688,"totalTrials":156,"cells":3700},{"EARLY_PHASE1":3701,"PHASE1":3707,"PHASE2":3709,"PHASE3":3711,"PHASE4":3713,"NA":3715},{"trials":3702,"activeCount":100},[3703],{"nctId":3680,"briefTitle":3681,"status":1284,"phases":3704,"primaryCompletion":3683,"completion":3684,"start":1828,"enrollment":100,"conditions":3705,"interventions":3706},[87],[3686],[3675,3688],{"trials":3708,"activeCount":100},[],{"trials":3710,"activeCount":100},[],{"trials":3712,"activeCount":100},[],{"trials":3714,"activeCount":100},[],{"trials":3716,"activeCount":100},[],{"intervention":3718,"totalTrials":637,"cells":3719},"Prednisone",{"EARLY_PHASE1":3720,"PHASE1":3722,"PHASE2":3724,"PHASE3":3726,"PHASE4":3728,"NA":3739},{"trials":3721,"activeCount":100},[],{"trials":3723,"activeCount":100},[],{"trials":3725,"activeCount":100},[],{"trials":3727,"activeCount":100},[],{"trials":3729,"activeCount":100},[3730],{"nctId":3731,"briefTitle":3732,"status":448,"phases":3733,"primaryCompletion":3734,"completion":3734,"start":3735,"enrollment":417,"conditions":3736,"interventions":3738},"NCT03833596","Exclusive Enteral Nutrition and Corticosteroids Therapy in Crohn's Disease (EENCD)",[91],"2019-11-01","2018-10-25",[3737],"Crohn's Disease",[3718],{"trials":3740,"activeCount":100},[3741],{"nctId":3742,"briefTitle":3743,"status":448,"phases":3744,"primaryCompletion":3745,"completion":3745,"start":3746,"enrollment":16,"conditions":3747,"interventions":3749},"NCT02908698","Effect of Oral Steroids on Skin Outcomes in Atopic Dermatitis",[92],"2018-08-08","2017-01-24",[3748],"Atopic Dermatitis",[3718],{"intervention":3751,"totalTrials":637,"cells":3752},"Enoxaparin",{"EARLY_PHASE1":3753,"PHASE1":3755,"PHASE2":3757,"PHASE3":3759,"PHASE4":3761,"NA":3763},{"trials":3754,"activeCount":100},[],{"trials":3756,"activeCount":100},[],{"trials":3758,"activeCount":100},[],{"trials":3760,"activeCount":100},[],{"trials":3762,"activeCount":100},[],{"trials":3764,"activeCount":100},[3765,3773],{"nctId":3766,"briefTitle":3767,"status":110,"phases":3768,"primaryCompletion":1678,"completion":1678,"start":1287,"enrollment":3769,"conditions":3770,"interventions":3772},"NCT02260908","OPtimal Timing of Thromboprophylaxis in Traumatic IntraCranial Haemorrhage - Pilot Study",[92],300,[3771],"Traumatic Intracranial Haemorrhage",[3751],{"nctId":3774,"briefTitle":3775,"status":146,"phases":3776,"primaryCompletion":3191,"completion":3191,"start":3777,"enrollment":3778,"conditions":3779,"interventions":3780},"NCT01589393","OPtimal Timing of Thromboprophylaxis in Traumatic IntraCranial Haemorrhage (OPTTTICH Feasibility Study)",[92],"2010-09",52,[3771],[3751],{"intervention":3270,"totalTrials":637,"cells":3782},{"EARLY_PHASE1":3783,"PHASE1":3785,"PHASE2":3787,"PHASE3":3793,"PHASE4":3795,"NA":3797},{"trials":3784,"activeCount":100},[],{"trials":3786,"activeCount":100},[],{"trials":3788,"activeCount":100},[3789],{"nctId":3263,"briefTitle":3264,"status":146,"phases":3790,"primaryCompletion":2137,"completion":2137,"start":3266,"enrollment":492,"conditions":3791,"interventions":3792},[89],[3268],[3270,3254],{"trials":3794,"activeCount":100},[],{"trials":3796,"activeCount":100},[],{"trials":3798,"activeCount":100},[3799],{"nctId":3800,"briefTitle":3801,"status":146,"phases":3802,"primaryCompletion":1287,"completion":1287,"start":1244,"enrollment":3803,"conditions":3804,"interventions":3806},"NCT01363570","Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes",[92],70,[3805],"Age Related Macular Degeneration",[3270],{"intervention":3808,"totalTrials":637,"cells":3809},"Morphine",{"EARLY_PHASE1":3810,"PHASE1":3812,"PHASE2":3814,"PHASE3":3816,"PHASE4":3818,"NA":3820},{"trials":3811,"activeCount":100},[],{"trials":3813,"activeCount":100},[],{"trials":3815,"activeCount":100},[],{"trials":3817,"activeCount":100},[],{"trials":3819,"activeCount":100},[],{"trials":3821,"activeCount":100},[3822,3831],{"nctId":3823,"briefTitle":3824,"status":110,"phases":3825,"primaryCompletion":3060,"completion":3060,"start":3826,"enrollment":568,"conditions":3827,"interventions":3829},"NCT02603848","Ibuprofen Compared to Morphine as a Pediatric Postoperative Pain Management Tool Following Inguinal Surgery",[92],"2017-02-27",[3828],"Inguinal Surgery",[3830,3808],"Ibuprofen",{"nctId":3832,"briefTitle":3833,"status":146,"phases":3834,"primaryCompletion":3835,"completion":3835,"start":1421,"enrollment":3836,"conditions":3837,"interventions":3840},"NCT02223377","Satisfactory Analgesia Minimal Emesis in Day Surgeries",[92],"2019-03",402,[3838,3839],"Pain","Post Operative Nausea and Vomiting",[3808,3841],"Hydromorphone",{"intervention":3388,"totalTrials":637,"cells":3843},{"EARLY_PHASE1":3844,"PHASE1":3846,"PHASE2":3848,"PHASE3":3854,"PHASE4":3856,"NA":3858},{"trials":3845,"activeCount":100},[],{"trials":3847,"activeCount":100},[],{"trials":3849,"activeCount":100},[3850],{"nctId":3381,"briefTitle":3382,"status":146,"phases":3851,"primaryCompletion":3384,"completion":3384,"start":3385,"enrollment":938,"conditions":3852,"interventions":3853},[89],[321],[3388,3372],{"trials":3855,"activeCount":100},[],{"trials":3857,"activeCount":100},[],{"trials":3859,"activeCount":100},[3860],{"nctId":3861,"briefTitle":3862,"status":146,"phases":3863,"primaryCompletion":3864,"completion":3864,"start":3865,"enrollment":841,"conditions":3866,"interventions":3867},"NCT03620422","Mannitol-Induced Cough Challenge in Healthy Controls and Subjects With Mild Allergic Asthma",[92],"2020-01-31","2019-01-11",[21,321],[3388],{"intervention":3869,"totalTrials":156,"cells":3870},"topical povidone-iodine after premedication with topical liquid eye drops",{"EARLY_PHASE1":3871,"PHASE1":3873,"PHASE2":3875,"PHASE3":3877,"PHASE4":3879,"NA":3881},{"trials":3872,"activeCount":100},[],{"trials":3874,"activeCount":100},[],{"trials":3876,"activeCount":100},[],{"trials":3878,"activeCount":100},[],{"trials":3880,"activeCount":100},[],{"trials":3882,"activeCount":100},[3883],{"nctId":3884,"briefTitle":3885,"status":146,"phases":3886,"primaryCompletion":2530,"completion":2530,"start":3430,"enrollment":3887,"conditions":3888,"interventions":3890},"NCT01898728","Comparison of the Effectiveness of Povidone-iodine in Reducing Conjunctival Bacterial Load Prior to Cataract Surgery in Patients Treated With a Lidocaine Gel Dilating Formulation Versus Eye Drops: A Randomized Controlled Trial",[92],101,[3889],"Cataracts",[3869,3891],"topical povidone-iodine after premedication with topical gel",{"intervention":3891,"totalTrials":156,"cells":3893},{"EARLY_PHASE1":3894,"PHASE1":3896,"PHASE2":3898,"PHASE3":3900,"PHASE4":3902,"NA":3904},{"trials":3895,"activeCount":100},[],{"trials":3897,"activeCount":100},[],{"trials":3899,"activeCount":100},[],{"trials":3901,"activeCount":100},[],{"trials":3903,"activeCount":100},[],{"trials":3905,"activeCount":100},[3906],{"nctId":3884,"briefTitle":3885,"status":146,"phases":3907,"primaryCompletion":2530,"completion":2530,"start":3430,"enrollment":3887,"conditions":3908,"interventions":3909},[92],[3889],[3869,3891],{"intervention":3911,"totalTrials":156,"cells":3912},"Combigan",{"EARLY_PHASE1":3913,"PHASE1":3915,"PHASE2":3917,"PHASE3":3919,"PHASE4":3921,"NA":3923},{"trials":3914,"activeCount":100},[],{"trials":3916,"activeCount":100},[],{"trials":3918,"activeCount":100},[],{"trials":3920,"activeCount":100},[],{"trials":3922,"activeCount":100},[],{"trials":3924,"activeCount":100},[3925],{"nctId":3926,"briefTitle":3927,"status":1284,"phases":3928,"primaryCompletion":3929,"completion":3929,"start":3929,"enrollment":100,"conditions":3930,"interventions":3932},"NCT02623023","Prophylaxis for Anti-VEGF-induced IOP Elevation",[92],"2019-01-01",[3931],"Ocular Hypertension",[3911],{"intervention":3934,"totalTrials":156,"cells":3935},"Glycerin Suppository",{"EARLY_PHASE1":3936,"PHASE1":3938,"PHASE2":3940,"PHASE3":3942,"PHASE4":3944,"NA":3946},{"trials":3937,"activeCount":100},[],{"trials":3939,"activeCount":100},[],{"trials":3941,"activeCount":100},[],{"trials":3943,"activeCount":100},[],{"trials":3945,"activeCount":100},[],{"trials":3947,"activeCount":100},[3948],{"nctId":3949,"briefTitle":3950,"status":110,"phases":3951,"primaryCompletion":1350,"start":1421,"enrollment":2488,"conditions":3952,"interventions":3954},"NCT02153606","Glycerin Suppositories Used Prophylactically in Premature Infants (SUPP): a Pilot Randomized Placebo-controlled Trial",[92],[3953],"Feeding Intolerance in Premature Infants",[3934],{"intervention":3956,"totalTrials":156,"cells":3957},"2% lidocaine",{"EARLY_PHASE1":3958,"PHASE1":3960,"PHASE2":3962,"PHASE3":3964,"PHASE4":3966,"NA":3968},{"trials":3959,"activeCount":100},[],{"trials":3961,"activeCount":100},[],{"trials":3963,"activeCount":100},[],{"trials":3965,"activeCount":100},[],{"trials":3967,"activeCount":100},[],{"trials":3969,"activeCount":100},[3970],{"nctId":3971,"briefTitle":3972,"status":1284,"phases":3973,"primaryCompletion":3974,"completion":3974,"start":3975,"enrollment":100,"conditions":3976,"interventions":3978},"NCT04515901","Spenopalatine Ganglion Block for Treatment of Post-dural Puncture Headaches",[92],"2022-11-11","2021-12-01",[3977],"Postdural Puncture Headache",[3956],{"intervention":3980,"totalTrials":156,"cells":3981},"Nutrition Consult and Protein Supplementation",{"EARLY_PHASE1":3982,"PHASE1":3984,"PHASE2":3986,"PHASE3":3988,"PHASE4":3990,"NA":3992},{"trials":3983,"activeCount":100},[],{"trials":3985,"activeCount":100},[],{"trials":3987,"activeCount":100},[],{"trials":3989,"activeCount":100},[],{"trials":3991,"activeCount":100},[],{"trials":3993,"activeCount":100},[3994],{"nctId":3995,"briefTitle":3996,"status":146,"phases":3997,"primaryCompletion":3998,"completion":3998,"start":3999,"enrollment":3803,"conditions":4000,"interventions":4001},"NCT04500366","GERAS Frailty Rehabilitation at Home During COVID-19",[92],"2021-11-01","2020-08-26",[1226],[3980],{"intervention":4003,"totalTrials":156,"cells":4004},"Gabapentin",{"EARLY_PHASE1":4005,"PHASE1":4007,"PHASE2":4009,"PHASE3":4011,"PHASE4":4013,"NA":4015},{"trials":4006,"activeCount":100},[],{"trials":4008,"activeCount":100},[],{"trials":4010,"activeCount":100},[],{"trials":4012,"activeCount":100},[],{"trials":4014,"activeCount":100},[],{"trials":4016,"activeCount":100},[4017],{"nctId":4018,"briefTitle":4019,"status":146,"phases":4020,"primaryCompletion":4021,"completion":4021,"start":1978,"enrollment":3887,"conditions":4022,"interventions":4024},"NCT01307202","Morphine Consumption in Joint Replacement Patients, With or Without Gabapentin Treatment",[92],"2011-02",[1788,4023],"Total Knee Replacement",[4003],{"intervention":4026,"totalTrials":156,"cells":4027},"eplerenone",{"EARLY_PHASE1":4028,"PHASE1":4030,"PHASE2":4032,"PHASE3":4034,"PHASE4":4036,"NA":4038},{"trials":4029,"activeCount":100},[],{"trials":4031,"activeCount":100},[],{"trials":4033,"activeCount":100},[],{"trials":4035,"activeCount":100},[],{"trials":4037,"activeCount":100},[],{"trials":4039,"activeCount":100},[4040],{"nctId":4041,"briefTitle":4042,"status":146,"phases":4043,"primaryCompletion":3191,"completion":3191,"start":479,"enrollment":4044,"conditions":4045,"interventions":4048},"NCT01650012","Eplerenone in Hemodialysis Trial",[92],158,[4046,4047],"Hemodialysis","End Stage Renal Disease",[4026],{"intervention":4050,"totalTrials":156,"cells":4051},"Trimethoprim",{"EARLY_PHASE1":4052,"PHASE1":4054,"PHASE2":4056,"PHASE3":4058,"PHASE4":4060,"NA":4062},{"trials":4053,"activeCount":100},[],{"trials":4055,"activeCount":100},[],{"trials":4057,"activeCount":100},[],{"trials":4059,"activeCount":100},[],{"trials":4061,"activeCount":100},[],{"trials":4063,"activeCount":100},[4064],{"nctId":4065,"briefTitle":4066,"status":110,"phases":4067,"primaryCompletion":4068,"completion":4068,"start":4069,"enrollment":4070,"conditions":4071,"interventions":4074},"NCT01140516","Effectiveness of Antibiotics Versus Placebo to Treat Antenatal Hydronephrosis",[92],"2024-09","2010-07",160,[4072,4073],"Hydronephrosis","Urinary Tract Infection",[4050],{"intervention":4076,"totalTrials":156,"cells":4077},"Hot Compress plus Tobramycin Drops and Ointment",{"EARLY_PHASE1":4078,"PHASE1":4080,"PHASE2":4082,"PHASE3":4084,"PHASE4":4086,"NA":4088},{"trials":4079,"activeCount":100},[],{"trials":4081,"activeCount":100},[],{"trials":4083,"activeCount":100},[],{"trials":4085,"activeCount":100},[],{"trials":4087,"activeCount":100},[],{"trials":4089,"activeCount":100},[4090],{"nctId":4091,"briefTitle":4092,"status":146,"phases":4093,"primaryCompletion":2136,"completion":1276,"start":4094,"enrollment":1060,"conditions":4095,"interventions":4100},"NCT01230593","Chalazion Conservative Treatment Trial",[92],"2010-11",[4096,4097,4098,4099],"Chalazion Unspecified Eye, Unspecified Eyelid","Chalazion Left Eye, Unspecified Eyelid","Chalazion Right Eye, Unspecified Eyelid","Chalazion Both Eyes",[4076,4101],"Hot compress plus Tobramycin\u002FDexamethasone Drops and Ointment",{"intervention":4101,"totalTrials":156,"cells":4103},{"EARLY_PHASE1":4104,"PHASE1":4106,"PHASE2":4108,"PHASE3":4110,"PHASE4":4112,"NA":4114},{"trials":4105,"activeCount":100},[],{"trials":4107,"activeCount":100},[],{"trials":4109,"activeCount":100},[],{"trials":4111,"activeCount":100},[],{"trials":4113,"activeCount":100},[],{"trials":4115,"activeCount":100},[4116],{"nctId":4091,"briefTitle":4092,"status":146,"phases":4117,"primaryCompletion":2136,"completion":1276,"start":4094,"enrollment":1060,"conditions":4118,"interventions":4119},[92],[4096,4097,4098,4099],[4076,4101],{"intervention":4121,"totalTrials":156,"cells":4122},"Senna",{"EARLY_PHASE1":4123,"PHASE1":4125,"PHASE2":4127,"PHASE3":4129,"PHASE4":4131,"NA":4133},{"trials":4124,"activeCount":100},[],{"trials":4126,"activeCount":100},[],{"trials":4128,"activeCount":100},[],{"trials":4130,"activeCount":100},[],{"trials":4132,"activeCount":100},[],{"trials":4134,"activeCount":100},[4135],{"nctId":4136,"briefTitle":4137,"status":110,"phases":4138,"primaryCompletion":4139,"completion":4139,"start":1325,"enrollment":4140,"conditions":4141,"interventions":4149},"NCT03593252","Bowel Preparation in Elective Pediatric Colorectal Surgery",[92],"2024-01-30",81,[4142,4143,4144,4145,4146,4147,4148],"Colostomy","Hirschsprung Disease - Pull Through","Necrotizing Enterocolitis","Inflammatory Bowel Diseases","Meconium Ileus","Bowel Obstruction","Elective Surgery",[4121,4150,4151,4152,4153,4151],"Sodium Picosulfate, Magnesium Oxide and Citric Acid","Metronidazole","Neomycin","Cefazolin",{"intervention":4150,"totalTrials":156,"cells":4155},{"EARLY_PHASE1":4156,"PHASE1":4158,"PHASE2":4160,"PHASE3":4162,"PHASE4":4164,"NA":4166},{"trials":4157,"activeCount":100},[],{"trials":4159,"activeCount":100},[],{"trials":4161,"activeCount":100},[],{"trials":4163,"activeCount":100},[],{"trials":4165,"activeCount":100},[],{"trials":4167,"activeCount":100},[4168],{"nctId":4136,"briefTitle":4137,"status":110,"phases":4169,"primaryCompletion":4139,"completion":4139,"start":1325,"enrollment":4140,"conditions":4170,"interventions":4171},[92],[4142,4143,4144,4145,4146,4147,4148],[4121,4150,4151,4152,4153,4151],{"intervention":4151,"totalTrials":156,"cells":4173},{"EARLY_PHASE1":4174,"PHASE1":4176,"PHASE2":4178,"PHASE3":4180,"PHASE4":4182,"NA":4184},{"trials":4175,"activeCount":100},[],{"trials":4177,"activeCount":100},[],{"trials":4179,"activeCount":100},[],{"trials":4181,"activeCount":100},[],{"trials":4183,"activeCount":100},[],{"trials":4185,"activeCount":100},[4186],{"nctId":4136,"briefTitle":4137,"status":110,"phases":4187,"primaryCompletion":4139,"completion":4139,"start":1325,"enrollment":4140,"conditions":4188,"interventions":4189},[92],[4142,4143,4144,4145,4146,4147,4148],[4121,4150,4151,4152,4153,4151],{"intervention":4152,"totalTrials":156,"cells":4191},{"EARLY_PHASE1":4192,"PHASE1":4194,"PHASE2":4196,"PHASE3":4198,"PHASE4":4200,"NA":4202},{"trials":4193,"activeCount":100},[],{"trials":4195,"activeCount":100},[],{"trials":4197,"activeCount":100},[],{"trials":4199,"activeCount":100},[],{"trials":4201,"activeCount":100},[],{"trials":4203,"activeCount":100},[4204],{"nctId":4136,"briefTitle":4137,"status":110,"phases":4205,"primaryCompletion":4139,"completion":4139,"start":1325,"enrollment":4140,"conditions":4206,"interventions":4207},[92],[4142,4143,4144,4145,4146,4147,4148],[4121,4150,4151,4152,4153,4151],{"intervention":4153,"totalTrials":156,"cells":4209},{"EARLY_PHASE1":4210,"PHASE1":4212,"PHASE2":4214,"PHASE3":4216,"PHASE4":4218,"NA":4220},{"trials":4211,"activeCount":100},[],{"trials":4213,"activeCount":100},[],{"trials":4215,"activeCount":100},[],{"trials":4217,"activeCount":100},[],{"trials":4219,"activeCount":100},[],{"trials":4221,"activeCount":100},[4222],{"nctId":4136,"briefTitle":4137,"status":110,"phases":4223,"primaryCompletion":4139,"completion":4139,"start":1325,"enrollment":4140,"conditions":4224,"interventions":4225},[92],[4142,4143,4144,4145,4146,4147,4148],[4121,4150,4151,4152,4153,4151],{"intervention":4227,"totalTrials":156,"cells":4228},"Single shot femoral nerve block",{"EARLY_PHASE1":4229,"PHASE1":4231,"PHASE2":4233,"PHASE3":4235,"PHASE4":4237,"NA":4239},{"trials":4230,"activeCount":100},[],{"trials":4232,"activeCount":100},[],{"trials":4234,"activeCount":100},[],{"trials":4236,"activeCount":100},[],{"trials":4238,"activeCount":100},[],{"trials":4240,"activeCount":100},[4241],{"nctId":4242,"briefTitle":4243,"status":146,"phases":4244,"primaryCompletion":1503,"completion":1503,"start":4245,"enrollment":822,"conditions":4246,"interventions":4248},"NCT01911949","USFIB at the Inguinal Ligament for Total Hip Arthroplasty",[92],"2017-01",[4247],"Post Surgical Pain",[4227],{"intervention":4250,"totalTrials":156,"cells":4251},"Proton Pump Inhibitors",{"EARLY_PHASE1":4252,"PHASE1":4254,"PHASE2":4256,"PHASE3":4258,"PHASE4":4260,"NA":4262},{"trials":4253,"activeCount":100},[],{"trials":4255,"activeCount":100},[],{"trials":4257,"activeCount":100},[],{"trials":4259,"activeCount":100},[],{"trials":4261,"activeCount":100},[],{"trials":4263,"activeCount":100},[4264],{"nctId":4265,"briefTitle":4266,"status":146,"phases":4267,"primaryCompletion":700,"completion":700,"start":4268,"enrollment":4269,"conditions":4270,"interventions":4272},"NCT00182260","A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Treatment of Patients With Chronic GERD",[92],"2000-01",216,[4271],"Gastroesophageal Reflux",[4250],{"intervention":3830,"totalTrials":156,"cells":4274},{"EARLY_PHASE1":4275,"PHASE1":4277,"PHASE2":4279,"PHASE3":4281,"PHASE4":4283,"NA":4285},{"trials":4276,"activeCount":100},[],{"trials":4278,"activeCount":100},[],{"trials":4280,"activeCount":100},[],{"trials":4282,"activeCount":100},[],{"trials":4284,"activeCount":100},[],{"trials":4286,"activeCount":100},[4287],{"nctId":3823,"briefTitle":3824,"status":110,"phases":4288,"primaryCompletion":3060,"completion":3060,"start":3826,"enrollment":568,"conditions":4289,"interventions":4290},[92],[3828],[3830,3808],{"intervention":4292,"totalTrials":156,"cells":4293},"Methacholine Chloride",{"EARLY_PHASE1":4294,"PHASE1":4296,"PHASE2":4298,"PHASE3":4300,"PHASE4":4302,"NA":4304},{"trials":4295,"activeCount":100},[],{"trials":4297,"activeCount":100},[],{"trials":4299,"activeCount":100},[],{"trials":4301,"activeCount":100},[],{"trials":4303,"activeCount":100},[],{"trials":4305,"activeCount":100},[4306],{"nctId":4307,"briefTitle":4308,"status":146,"phases":4309,"primaryCompletion":1422,"completion":1422,"start":480,"enrollment":150,"conditions":4310,"interventions":4311},"NCT01919424","Comparison of the Methacholine PC20 Between the Trudell Aeroeclipse* II Ban Nebulizer and the Wright Nebulizer",[92],[21],[4292],{"intervention":4313,"totalTrials":156,"cells":4314},"Zostavax",{"EARLY_PHASE1":4315,"PHASE1":4317,"PHASE2":4319,"PHASE3":4321,"PHASE4":4323,"NA":4325},{"trials":4316,"activeCount":100},[],{"trials":4318,"activeCount":100},[],{"trials":4320,"activeCount":100},[],{"trials":4322,"activeCount":100},[],{"trials":4324,"activeCount":100},[],{"trials":4326,"activeCount":100},[4327],{"nctId":4328,"briefTitle":4329,"status":146,"phases":4330,"primaryCompletion":1286,"completion":1286,"start":2094,"enrollment":4331,"conditions":4332,"interventions":4333},"NCT01328548","Zoster Vaccine Response in the Frail Elderly",[],241,[2225],[4313],{"intervention":4335,"totalTrials":156,"cells":4336},"Autologous conditioned plasma",{"EARLY_PHASE1":4337,"PHASE1":4339,"PHASE2":4341,"PHASE3":4343,"PHASE4":4345,"NA":4347},{"trials":4338,"activeCount":100},[],{"trials":4340,"activeCount":100},[],{"trials":4342,"activeCount":100},[],{"trials":4344,"activeCount":100},[],{"trials":4346,"activeCount":100},[],{"trials":4348,"activeCount":100},[4349],{"nctId":4350,"briefTitle":4351,"status":146,"phases":4352,"primaryCompletion":4353,"completion":4353,"start":3777,"enrollment":2531,"conditions":4354,"interventions":4356},"NCT01170312","Arthroscopic Surgery and Platelet Rich Plasma In Rotator Cuff Tear Evaluation",[92],"2012-08",[4355],"Rotator Cuff Tear",[4335],{"intervention":4358,"totalTrials":156,"cells":4359},"Sugammadex",{"EARLY_PHASE1":4360,"PHASE1":4362,"PHASE2":4364,"PHASE3":4366,"PHASE4":4368,"NA":4370},{"trials":4361,"activeCount":100},[],{"trials":4363,"activeCount":100},[],{"trials":4365,"activeCount":100},[],{"trials":4367,"activeCount":100},[],{"trials":4369,"activeCount":100},[],{"trials":4371,"activeCount":100},[4372],{"nctId":4373,"briefTitle":4374,"status":110,"phases":4375,"primaryCompletion":1348,"completion":1349,"start":433,"enrollment":568,"conditions":4376,"interventions":4378},"NCT03803982","Deep Neuromuscular Relaxation Optimizing Low-Pressure Bariatric Surgery",[92],[4377],"Bariatric Surgery",[4358],{"intervention":4380,"totalTrials":156,"cells":4381},"Non-Opioid Prescription and Infographic",{"EARLY_PHASE1":4382,"PHASE1":4384,"PHASE2":4386,"PHASE3":4388,"PHASE4":4390,"NA":4392},{"trials":4383,"activeCount":100},[],{"trials":4385,"activeCount":100},[],{"trials":4387,"activeCount":100},[],{"trials":4389,"activeCount":100},[],{"trials":4391,"activeCount":100},[],{"trials":4393,"activeCount":100},[4394],{"nctId":4395,"briefTitle":4396,"status":146,"phases":4397,"primaryCompletion":4398,"completion":4398,"start":4399,"enrollment":4400,"conditions":4401,"interventions":4404},"NCT04566250","Non-Opioid Prescriptions After Arthroscopic Surgery in Canada (NO PAin)",[92],"2022-04-01","2021-02-24",200,[4402,4403],"Knee Arthroscopy","Shoulder Arthroscopy",[4380],{"intervention":4406,"totalTrials":156,"cells":4407},"SSRIs",{"EARLY_PHASE1":4408,"PHASE1":4410,"PHASE2":4412,"PHASE3":4414,"PHASE4":4416,"NA":4418},{"trials":4409,"activeCount":100},[],{"trials":4411,"activeCount":100},[],{"trials":4413,"activeCount":100},[],{"trials":4415,"activeCount":100},[],{"trials":4417,"activeCount":100},[],{"trials":4419,"activeCount":100},[4420],{"nctId":4421,"briefTitle":4422,"status":146,"phases":4423,"primaryCompletion":4424,"completion":4424,"start":4425,"enrollment":4426,"conditions":4427,"interventions":4428},"NCT02285699","The Gut Microbiota in Obsessive-Compulsive Disorder",[92],"2016-03-01","2014-11-01",43,[436],[4406],{"intervention":4430,"totalTrials":156,"cells":4431},"Caudal Block Anesthesia",{"EARLY_PHASE1":4432,"PHASE1":4434,"PHASE2":4436,"PHASE3":4438,"PHASE4":4440,"NA":4442},{"trials":4433,"activeCount":100},[],{"trials":4435,"activeCount":100},[],{"trials":4437,"activeCount":100},[],{"trials":4439,"activeCount":100},[],{"trials":4441,"activeCount":100},[],{"trials":4443,"activeCount":100},[4444],{"nctId":4445,"briefTitle":4446,"status":110,"phases":4447,"primaryCompletion":3216,"completion":3216,"start":2337,"enrollment":4448,"conditions":4449,"interventions":4451},"NCT02512887","Caudal vs Local Anesthesia in Hypospadias",[92],224,[4450],"Hypospadias",[4430,4452],"Dorsal Penile Block Anesthesia",{"intervention":4452,"totalTrials":156,"cells":4454},{"EARLY_PHASE1":4455,"PHASE1":4457,"PHASE2":4459,"PHASE3":4461,"PHASE4":4463,"NA":4465},{"trials":4456,"activeCount":100},[],{"trials":4458,"activeCount":100},[],{"trials":4460,"activeCount":100},[],{"trials":4462,"activeCount":100},[],{"trials":4464,"activeCount":100},[],{"trials":4466,"activeCount":100},[4467],{"nctId":4445,"briefTitle":4446,"status":110,"phases":4468,"primaryCompletion":3216,"completion":3216,"start":2337,"enrollment":4448,"conditions":4469,"interventions":4470},[92],[4450],[4430,4452],{"intervention":3841,"totalTrials":156,"cells":4472},{"EARLY_PHASE1":4473,"PHASE1":4475,"PHASE2":4477,"PHASE3":4479,"PHASE4":4481,"NA":4483},{"trials":4474,"activeCount":100},[],{"trials":4476,"activeCount":100},[],{"trials":4478,"activeCount":100},[],{"trials":4480,"activeCount":100},[],{"trials":4482,"activeCount":100},[],{"trials":4484,"activeCount":100},[4485],{"nctId":3832,"briefTitle":3833,"status":146,"phases":4486,"primaryCompletion":3835,"completion":3835,"start":1421,"enrollment":3836,"conditions":4487,"interventions":4488},[92],[3838,3839],[3808,3841]]